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SUMMARY 
This research centers on the use of fuzzy systems theory to more 
realistically model physician decision making processes. Various 
physician decision processes, including the general diagnostic and 
treatment processes, are described and detailed so that their fuzzy 
aspects might be discerned. Deficiencies of past mathematical repre-
sentations of both fuzzy and nonfuzzy decision aspects are outlined 
and evaluated critically. 
From these analyzed decision processes, the diagnosis decision 
process was selected as the most appropriate for mathematical modelling 
via fuzzy set theory. The diagnosis decision process includes decisions 
upon medical hypotheses, preliminary diagnoses, and final diagnoses. 
Patient information including past history, present symptoms, observed 
signs, or test results are needed to reach these various diagnosis 
decisions. Fuzzy set theory is primarily used to evaluate this patient 
information so that it can be incorporated into the proposed diagnosis 
decision model. The model of the actual diagnosis decision uses cluster 
analysis techniques to determine the proper diagnosis. The patient's 
sickness is clustered with the most similar disease stage using a 
revised Euclidean distance similarity measure. 
An illustrative example of the diagnosis decision model is 
offered to clarify and illustrate fuzzy and nonfuzzy aspects of the 
proposed model. In this instructive example, the model reaches medical 
hypotheses for rheumatic valvular heart diseases. The diagnosis 
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decision model is analyzed and validated through this example. Medical 
hypotheses reached by a physician and the fuzzy computerized model are 
contrasted so that problem areas or discrepancies are uncovered. Sug-
gestions are proposed to remedy these discrepancies in future research. 
As a diagnostic tool, the initial accuracy of the fuzzy diagnosis model 
was not extremely high, but the results were encouraging enough to 
warrant further model refinement and applications. The decision model 
did succeed in representing more of the influential aspects important 
to actual physician decisions. 
CHAPTER I 
INTRODUCTION 
In recent years, more and more attention has been focused on 
various problems in the health systems field. Due to increased public 
demands, government as well as private research organizations have 
increased their spending in an effort to improve health care and to 
better understand the problems confronted by people involved in the 
health fields. Various techniques, including those of mathematical 
modelling, have been used by physicians, engineers, and mathematicians 
to analyze different problem area to obtain these improvements. 
One specific problem area; that of dicision making by physicians, 
has received much attention in recent years. Decisions made by physici-
ans and psychotherapists during the initial interview with the patient, 
the diagnostic process, and the treatment process have been modelled 
extensively. A variety of modelling techniques have been used, 
including those of operations research, decision theory, and pattern 
recognition. 
The physicians' patient oriented decisions are the primary 
points of concern in this research. The main thrust of this thesis 
is directed toward the analysis of decisions made by the physicians 
who act as clinicians, rather than physicians in general. A clinician 
is the physician in direct contact with the patient, the one who 
accepts responsibility for helping the patient, and the one who offers 
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relief to the patient. This eliminates physicians in laboratories, 
pathologists and others who do not directly influence the patient's 
care. 
Several benefits should emerge from the analyzation and model-
ling of these physicians' decisions. From an educational viewpoint, 
physicians receive only limited formal training in the mathematical 
analysis of decision making. Many believe their decision making is 
unsusceptible or too complex for such investigation and modelling. As 
a result, physicians benefit little from the use of mathematics in 
evaluating the structure, logic and information used in their deci-
sions. If precise, realistic models are created and scientifically 
presented, physicians will hopefully interpose the benefits into 
specific applications of decision making. By employing these models in 
specialized areas of medicine, physicians should strengthen their 
ability to analyze decisions, recognize contributory factors and evalu-
ate possible alternatives. Due to increasing requirements upon 
physicians, such mathematical models have often been aimed at directly 
assisting or eliminating the physician from numerous decisions. This 
has become more feasible with the advent of computers and an embryonic 
effort by medical personnel to collect and compile the vast quantities 
of information needed for data bases. Models directed toward com-
puterized diagnosis, treatment selection, and test evaluation have 
multiplied and matured over the past decade. Regretfully, these models 




Purpose of the Research  
The objective of this research is to invoke the concepts and 
methods of fuzzy decision theory in an effort to more realistically 
model the physicians' decision processes. To attain this, the general 
diagnostic process, the general treatment process and constraints by 
the environment are first developed and analyzed in detail. The fuzzy 
aspects, not usually incorporated in previous models, are specifically 
identified and exemplified. A summary of previous modelling tech-
niques is given and their deficiencies as well as misrepresentations 
are outlined. 
Based on this analysis, a more realistic model of the diagnosis 
decision process is presented through the use of fuzzy set theory. 
Attempts are made to quantify those aspects which are fuzzy, difficult 
to quantify, or imprecise. For a specialized area of medicine, an 
illustrative example of this general model is given. Model computer-
ization and validation is then exhibited for diagnoses in this medical 
field. 
Background  
Models of physicians' decision processes presented to 
date use many techniques which are prevalent in classical decision 
theory. Variations of Bayesian statistics, decision trees, pattern 
classification techniques and others have been used in modelling these 
processes. Unfortunately, many fail to include important aspects of 
the actual decisions. When applied to specific disease areas, the 
accuracy of such models does not even approach that required of 
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physicians [23]. Thus, more detailed analysis of these decision 
processes and more precise, realistic models are needed to produce 
accurate results for educational or applied purposes. 
To accomplish this, attempts are made to alleviate certain 
discrepancies of past modelling techniques. One severe shortcoming 
of these past techniques is their inability to differentiate between 
fuzziness and randomness in the physicians , decision processes. 
Randomness deals with the uncertainty of membership in a well defined 
set, and can be effectively represented using probability theory. But 
many aspects of these decision processes are intrinsically fuzzy, not 
random. If the boundary of the set cannot clearly be defined, then 
certain aspects of the decision cannot be represented as being included 
in the set or excluded from the set. Thus, the aspect becomes a member 
of a fuzzy set and is represented by a degree of membership in that set. 
Clearly, techniques being used to represent randomness should not be 
used to represent this fuzziness. Unfortunately, in many instances, 
past models have done just that. To remedy this situation, fuzzy 
aspects are illustrated throughout the analysis of the diagnostic and 
treatment process. Fuzzy set theory is then used to model such 
aspects in the diagnosis decision process. 
Study of Literature  
The literature relevant to this research on physician decision 
making has been restricted to the following main areas: 
1. Medical references. 
2. References on mathematical modelling, applied to 
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physician decision making. 
3. References on fuzzy set theory. 
These literature groups comprise the formal information used in the 
analysis, modelling, and simulation of the diagnostic and treatment 
processes. 
Medically oriented references on physician decision making and 
cardiovascular diseases have been used extensively in the systems 
description phase as well as in the example of the resulting mathematical 
model. Literature oriented towards the decision processes specifically 
involves the initial interview with the patient, the diagnostic reason-
ing process, and the test selection process. In his work concerning 
the patient's initial interview, Stevenson [15] details in depth the 
interactive events between physician and patient. Relevant aspects 
of the patient's history, such as previous illnesses, past medical 
disorders, and family background, are thoroughly discussed. Diffi- 
culties encountered by the physician during the interview, variations 
and contrasts in interviews, and the physician's ability to guide and 
control the interview also receive specific analytical attention. 
Research by Krieg, Gambino, and Galen [10] gives insight into 
the proper medical basis for diagnostic test selection. Measures of 
test usefulness, outlined later in this research, are proposed for 
determining the medical effectiveness of a particular test. Due to 
ever increasing costs, the need for a test is also questioned whenever 
the results may be nonessential to the diagnosis decision being made. 
Informal criteria for evaluation of this need is therefore proposed. 
The most thorough medical analysis of the diagnostic and 
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treatment decision processes is offered by Feinstein. His primary 
work [3] illustrates in depth such aspects of clinical judgment as 
symptom interpretation and designation, sign observation, taxonomy 
problems encountered when reaching a diagnosis, and treatment and 
therapy considerations and selection. His other related research [4,5] 
gives one of the few detailed insights into the diagnostic reasoning 
process used by physicians to explain signs, symptoms and other 
attributes when converging on a diagnosis. Criticism of past mathe-
matical techniques used to represent physician decision making pre-
vails in his works, since oversimplification, omission or misrepre-
sentation by researchers alters the actual decision processes. 
The second major group of medical references contains informa-
tion used for the illustrative example of the diagnostic model. This 
information centers on heart disease, but more specifically rheumatic 
valvular disease. The literature from this category is basically similar 
in content and is distinguishable only by the quantity and quality of 
information relevant to the example. The most useful research in this 
specialized field is attributable to Reichek, Shelburne, an6' Perloff [13]. 
Each of the rheumatic valvular diseases is detailed with respect to 
cause, disease development, and treatment. The patient's past history 
and present symptoms, needed for the model example, are enumerated and 
interrelated. Similar works have also been presented by Conn and 
Horowitz [2] and Hurst [8]. Both of these are somewhat voluminous, since 
all cardiovascular diseases and disorders are d_scussed, but the informa-
tion conveyed remains pertinent. 
Mathematical modelling of physicians' decision processes 
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encompasses the next group of references. Comprehensive research b;! 
Croft [23] cites the most prevalent computerized diagnosis techniques 
available at the present time. Assumptions these models require and 
problems confronted by their use for computerized diagnosis are expli-
cated. Variations on Bayesian and clustering models are listed and 
explained. These approaches are then evaluated with respect to their 
accuracy in reaching the proper oiagnosis. 
Jacquez [34] has assembled an excellent collection of modelling 
theory and applications in the diagnostic decision domain. This volume 
is essentially the Proceedings of the Second Conference on the Diagnostic 
Process held at the University of Michigan in 1971. Empirical and 
statistical diagnostic models are therein elucidated and possible 
heuristic approaches are outlined. 
A somewhat new and creative approach to the analysis of the 
initial physician decisions has been introduced by Bellman and Smith [19]. 
Although the analysis and model deal with the initial psychotherapeutic 
interview, the mathematical approach is still very relevant to initial 
interviews by other physicians as well. The systems analysis of this 
adaptive decision process defines possible systems, influences and 
responses which are pertinent to the interview and its results. The 
resultant simulations found in the final phases of this work are very 
similar to patient-physician interactions of history and symptoms 
modelled later in this research. 
Chesler, Hershdorfer and Lincoln [22] have developed a systems 
analysis of the diagnostic and treatment processes, aimed at the use 
of specific clinical information. Their results are somewhat similar 
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to those uncovered in the systems description in Chapter II, even 
though research for this thesis was performed without knowledge of 
the above reference. The information used for their research was 
gained without extensive physician input and lacks much of the medically 
oriented data found herein. 
There exists an abundance of mathematical applications for 
decisions made during different phases of the diagnostic and treatment 
processes, many of which are similar to those mentioned above. Since 
most of these will be noted and evaluated in Chapter II of this research, 
additional comments on previous models will be delayed to this time. 
The last section of literature, relevant to the modelling of the 
initial phase of the diagnostic process, concerns fuzzy set and fuzzy 
systems theory. The concept of a fuzzy set was first introduced by 
Zadeh [60] in 1965 to differentiate between randomness and fuzziness. 
Since that time, references on fuzzy sets have increased dramatically 
as more and more theory and applications have been developed. An early 
contribution due to Bellman, Kalaba, and Zadeh [56] develops a framework 
for abstraction and pattern classification through fuzzy sets. Based 
on sample data of a fuzzy set, a general membership function can be 
constructed to represent the fuzzy set as a whole. Then membership 
of a new element can be classified according to this general membership 
function. 
Kochen [58,59] and Zadeh [63] have introduced and developed the 
application of fuzzy set theory to fuzzy semantics, fuzzy adjectives, 
and psychology. This was done via prominent periodicals and recently 
at the U.S. Japanese Seminar on Fuzzy Sets and Their Applications. 
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Techniques used in these references are somewhat similar to those 
incorporated in this research to quantify fuzzy symptom descriptions 
in the initial information gathering session. Included in these 
references are experimental results verifying the true fuzziness of 
specific, imprecise terms. 
Another application of fuzzy theory, initiated by Bellman and 
Zadeh [52], has been in the area of decision making in a fuzzy environ-
ment. For this problem, the system under consideration is nonfuzzy 
(real numbers), while constraints and goals are fuzzy in nature, 
requiring the intersection of fuzzy constraint and goal sets to obtain 
the solution set. Although the system under consideration in this 
research is also fuzzy, certain notions discussed by Bellman and Zadeh 
seem applicable to this effort. Fuzzy allocation processes, investi-
gated and developed by Esogbue [55,56], give further insight into the 
various uses of fuzzy theory. Examples are given for the evaluation 
of membership functions, fuzzy constraints, and fuzzy objectives. 
Applications of this model to the allocation of funds for cancer 
research have been suggested and deemed feasible. 
The development of the theory of fuzzy sets has grown rather 
rapidly since its conception. Included in these developments is a 
variety of theory, the most directly relevant of which deals with such 
concepts as the entropy of a fuzzy set [54], shadow of a fuzzy set [61], 
similarity relations and fuzzy ordering [64], and L-Fuzzy sets [57]. 
Certain specific aspects of fuzzy theory are given as an appendix to 
this research. 
CHAPTER II 
MEDICAL DECISION MAKING: A SYSTEMS DESCRIPTION 
In the following sections, the physicians' decision processes 
are analyzed in detail. The general diagnostic process, the general 
treatment process, and limitations imposed by the environment are 
extensively discussed. Accompanying each of these discussions is a brief 
summary and evaluation of past mathematical techniques used to model 
these decision processes. The information needed for this descriptive 
analysis was obtained from key medical journals and references, fol-
lowed by mail questionnaires and personal interviews with local 
physicians. 
The General Diagnostic Process  
The diagnostic decision process is a sequence of decisions made 
by a physician in at attempt to identify and explain the ailments, 
disorders, and diseases present in a particular sick patient. This 
process involves the acceptance of the patient into the physician's care, 
and the collection and evaluation of pertinent information at various 
intermittent stages. Such information, obtained through discussion, 
observation, and tests, is significant to the convergence upon effec-
tive preliminary and final diagnoses. To study the general diagnostic 
process, this analysis has been structured into four subsystems, which 
are illustrated in Figure 1. The interactions between these subsystems 
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Figure 1. Systems Diagram of the General Diagnostic 
and Treatment Processes. 
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subsystems themselves, are discussed in individual sections later in 
the chapter. 
In an effort to clarify the meaning of certain terms used in 
this portion of the research, the following definitions are given: 
Attributes or Manifestations - signs, symptoms, pieces of 
pertinent history, test results, or other bits of information 
known about the sick patient. 
Symptoms - the patient's subjective feelings or discomforts 
associated with his present sickness. 
Signs - the findings observed by a physician during physical 
examination of the sick patient. 
Test - any clinical activity used for obtaining additional 
information about the sick patient (E.C.G., X-Rays, tests 
on body fluids and tissue, and other methods evaluating the 
state of the patient). 
Diagnosis - the identifying of a disease, group of diseases, or 
other reason that explains the occurrence of the patient's 
attributes. 
Hypothesis - a medical conjecture regarding the disease or cause 
of disease in the patient, based solely upon the past history 
and present symptoms. 
Preliminary Diagnosis - an early diagnosis, initially made 
following physical examination of the patient and modified 
by clinical and diagnostic test results. 
Final Diagnosis - the endpoint of the diagnostic process, upon 
which treatment or therapy is based. 
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Initial Contact With the Physician's Environment  
This initial subsystem of the diagnostic process involves the 
sick patient contacting the physician's environment (home, office, 
hospital, etc.) in an effort to obtain some sort of medical assistance. 
This subsystem includes the acceptance of a new patient into the 
physician's care, as well as the renewed care of a previous patient 
with an undiagnosed sickness. The sick patient contacts the physician's 
environment either by entering his office or by telephoning his home, 
office or hospital. 
With the exception of the emergency room of a hospital, rela-
tively few patients enter the physician's office without an appointment 
of some sort. According to the results of the questionnaire, less than 
ten percent of the patients seen by each physician entered his office 
without a previous appointment. Some physicians accept patients only 
by appointment, so the patient may be turned away from the physician's 
office altogether. If a patient enters a physician's office seeking 
assistance, he may be turned away or referred to another physician, he 
may be given a future appointment, or he may wait and see the physician 
directly. Whenever the patient comes into direct physical contact with 
the physician, he enters into our next decision subsystem. 
The majority of sick patients contact the physician's office, 
hospital, or home over the telephone. If the patient has been 
accepted into the physician's care, he may desire only a future appoint-
ment, or may want or need more immediate relief. 
Given that this patient seeks immediate relief over the telephone 
and his sickness has not been observed or diagnosed by a physician, 
a special case of the diagnostic and treatment process emerges. First 
of all, the physician must make his decisions based solely on obtain-
able information. In this case, the obtainable information is limited 
to the patient's past history and the symptoms related over the tele-
phone. Thus, the physician develops a hypothesis, preliminary diag-
nosis, or final diagnosis based primarily on verbal interactions between 
physician and patient. Note that this verbal interaction will be dis-
cussed in a subsequent subsystem. 
From comments in the questionnaire, most physicians in this 
situation would grant an appointment time reflecting the urgency 
associated with the hypothesis, preliminary diagnosis, or final diag-
nosis. If the physician determines emergency relief or hospitalization 
is necessary, the patient is either met by the physician at the hospital 
or the physician recommends emergency room treatment. If no emergency 
exists, the earliest appointment time would depend upon the needs of 
the patient and the availability of the physician. 
For these telephone cases where the physician is unable to see 
the patient soon, and no emergency exists, certain relief decisions must 
be made. The remits of the questionnaire revealed that two-thirds of 
the physicians would offer prescription drugs as relief if the symptoms 
warranted. Prescription drugs mentioned by specific physicians included 
antibiotics, antihistamines, analgesics, and pain medication. Factors 
influencing the physician's selection of prescription drugs include 
familiarity and knowledge of the patient, pain and discomfort of the 
patient, and the physician's interpretation of the urgency of the situa-
tion. Because of lack of information or lack or urgency, the physician 
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may offer no immediate prescription relief and request to see the patient 
during his office hours. Approximately one-half the physicians questioned 
offered nonprescription relief to their patients warranting it. This 
relief seem to be temporary in nature and examples include antipyretics 
(aspirin), laxatives, and cough medicine. Three out of five physicians 
offering prescription or nonprescription relief in this situation 
occasionally did not recommend to see the patient at a later date. 
Factors given that influence this decision include knowledge of the 
patient, lack of danger or severity, and physician's satisfaction with 
the diagnosis and treatment selection. Thus, in these instances, diag-
nostic decisions have been made without physician observation or test 
results, and the treatment selection was deemed satisfactory and permanent. 
Since this subsystem introduces the general diagnostic decision 
process, most of the decisions are procedural and lack the structure 
or need for modelling. The preceding special case was analyzed in 
this section because the patient never came into direct contact with 
the physician. Modelling techniques used for the general diagnostic 
and treatment processes, discussed in subsequent subsystems, can be 
modified to deal with this special case. Evaluation of these modelling 
techniques will also be given at that time. 
Initial Interview: Information Gathering Session  
This stage of the diagnostic process begins with the patient's 
initial direct contact with the physician. During this subsystem the 
physician attempts to gain information about the state of the sick 
patient, on which he can base his diagnosis. The following information 
can be obtained in this initial interview: 
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1. The patient's history 
a. Past history 
b. Symptoms of the present sickness related 
to the physician by the patient. 
2. The signs observed by the physician while performing 
the physical examination. 
The past history supplies data about the specific patient or host of 
the disease. The signs and the symptoms are interpreted as inter-
actions between the host or patient and the disease. The only other 
information available concerns data on the disease itself and is 
obtained in the latter subsystem of clinical and diagnostic testing. 
The quality and quantity of this pertinent information obtained 
during the initial interview influences the possibility of a correct 
or incorrect diagnosis. During this interactive process between the 
patient and the physician, it is important that the information be as 
precise as possible, given the constraints of the subsystem. One major 
constraint, imposed by the physician, involves the limitations of time. 
The questionnaire revealed that almost every physician had an appoint-
ment time of fifteen minutes in length, with variations allowed for 
special examinations. Thus, the lack or availability of this time 
plays an important role in determining the number and preciseness of 
the patient's attributes. Other such constraints of this subsystem are 
given in detail when they are encountered. 
The first information relevant to this subsystem is the patient's 
past history. Each physician questioned during this research required 
a past medical history from his new patients. Their answers also 
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revealed that this history taking is usually performed by themselves, 
rather than by their office personnel. Information requested for the 
medical history usually includes name, age, sex, religion, racial or 
national origin, occupation, residency, education, marital status, 
family background, physical characteristics, past health, and previous 
diseases and disorders. This history gives a good basis for future 
medical care as well as insight into the past state of health of the 
patient. Frequent illnesses, similar sicknesses, and past diseases often 
relate to present and future medical problems. Occupation, national 
origin, education, residency, and family background directly influence 
physical and emotional factors relevant to the well being of the 
patient. The patient's reactions and answers to pertinent questions 
also gives a physician a better understanding of the patient and his 
communicative abilities. Psychotherapists and psychiatrists use much 
of this information to a greater extent than other physicians in their 
analysis of the patient. 
If the patient has received assistance and treatment before, 
his medical history is already known by the physician. When the 
physician meets with the patient, he notes this past history and uses 
this information for decisions in the present diagnostic process. Past 
symptoms, signs, test results, treatment, and disorders may be present 
or important to the current sickness. Other information the physician 
has at this time includes relief he may have offered the patient for 
this sickness over the telephone, as detailed in the previous subsystem. 
Also, many physicians record some information about the patient's 
sickness or needs at the time the patient makes an appointment, giving 
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them some idea of the possible problems and decisions that might arise. 
After the patient's past history has been taken or noted, the 
symptoms of the sickness related to the physician by the patient. 
This relation is a dynamic interaction since the number and preciseness 
of these symptoms develop or increase as the interview progresses. 
Often the patient is not with the physician when he is experiencing 
these symptoms, so the symptom description becomes extremely important. 
Usually patients relate the most discomforting symptoms first, so the 
physician must properly question the patient to insure a complete list 
of symptoms. Physicians admit that patients often describe these 
symptoms in imprecise, unclear or fuzzy terms, but through verbal and 
nonverbal physician-patient interaction this impreciseness will hope-
fully decrease. When detail is lacking, distinguishing features of 
symptoms are vague and discrete disorders become blurred and confused 
with each other. Thus, these imprecise symptoms should be clarified 
into nonfuzzy terms by the patient, if possible. But often the best 
description of a symptom still remains vague and imprecise. Occa-
sionally, a physician may ask a patient to perceive a symptom over a 
period of time to more clearly describe the discomfort as well as its 
location, frequency, or degree of discomfort. 
The questionnaire identified several factors influencing the 
patient's ability to reIlte'symptuns in a precise and clear way. An 
attempt was made to have these factors quantified according to their 
influence, but the physicians too often disagreed as to the importance 
of each of these factors. The variation of each factor in the rating 
scheme was such that the only precise conclusions possible would be 
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that the factors varied in importance from physician to physician or 
that the factors were not susceptible to such a grading by physicians. 
These factors can be classified into the following three categories: 
1. The patient's lack of knowledge regarding medical 
terminology used to precisely describe symptoms. 
2. Factors influencing the patient's ability to communicate. 
3. Constraints and limitations of the physician. 
The first of these categories involves the patient's lack of familiarity 
with medical terms used to describe symptoms. The limitations of 
everyday language and absence of common nomenclature between physician 
and patient hinders the definition and interpretation of symptoms. The 
second category deals with personal characteristics of the patients 
such as education, socio-economic, background, shyness, modesty, apathy 
or indifference, unfamiliarity with the surroundings, and other 
patient factors affecting symptom description. The most influencial 
of these seemed to be the patient's education, socio-economic back-
ground, and age. The last category includes constraints imposed by 
the physician or limitations of the physician himself. Constraints 
imposed by physicians include the time constraint mentioned earlier, 
as well as physician thoroughness. Physician limitations include the 
physician's ability to relate to the patient, ask the proper questions, 
and seek honest and complete answers. 
Aside from a description of the symptom itself, several other 
aspects of the symptom are related in this physician-patient inter-
action. These aspects make up what is called the symptom profile. 
Included in this symptom profile are the following aspects of the 
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symptom: degree of severity, location, longevity, and continuity. 
The severity of symptoms frequently varies. Physicians noted 
that this variation may influence or change the final diagnosis or 
treatment of a patient. For instance, pain in a particular location 
may vary over a wide spectrum to change the symptom's identification 
with a particular ailment. Many symptoms fluxuate, often increasing 
in severity, reach a peak of maximum severity and then decline. The 
degree of severity for a symptom of this type could give insight into 
the disease development in individual patients. 
Patients usually describe this degree of severity using terms 
such as bad, severe, mild, sharp, and other descriptive adjectives. 
These terms seem rather fuzzy in nature and lack any obvious quanti-
tative structure. But in reaching a diagnosis, these levels of 
severity must be defined and interpreted by the physician. Note that 
in some instances the description and degree of severity of a symptom 
both lack preciseness and clear definition. 
The next aspect of the symptom profile concerns the location 
of the symptom. Generally, location is the most important detail 
of a symptom since it can determine whether a symptom exists as non-
contributory to critical. Some symptoms, such as fatigue, weakness, 
and depression cannot be associated with any specific location of the 
body, while others, such as chest pain, may only be limited to a 
generalized region. 
The last two factors of the profile are symptom longevity and 
continuity. The longevity of the symptom is defined as the length of 
time the patient has experienced or observed the given symptom. This 
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aspect may be an indicator of the progress and severity of the disorder 
or disease in the patient. The continuity factor determines whether 
the symptom is continuous or intermittent in occurrence. If the 
symptom occurs intermittently, then the frequency, duration, sudden 
or gradual onset and sudden or gradual recovery should be noted. 
Other factors, such as sleep, fatigue, and eating, that accompany 
the incidence of the symptom can also be distinguished. 
The physician must interpret and determine these specifics 
which make up the symptom profile. His careful questioning should 
eliminate much of the fuzziness normally associated with patients' 
descriptions. At the end of the symptom explication, the physician 
designates a medical name accounting for each sensation and the speci-
fications (profile) related during the interview. This medical desig-
nation is usually nonfuzzy in nature. However, the severity quantifi-
cation terms remain vague and imprecise, similar to the descriptive 
adjectives used by patients. After the physician finishes designation 
of the symptoms and profiles, he forms a hypothesis on which he bases 
his physical examination. 
The last information gained from the initial interview comes 
from the physician's observation of the patient's signs. This includes 
visual and physical examination of the patient, using basic physical 
examining instruments, such as stethoscopes, thermometers, and others, 
to aid in identifying, medically designating, and qualifying these 
signs. Some symptoms become signs when the physician can observe 
what the patient has verbally explicated. Any information gained by 
the patient description can be added to the physician's own perceptions. 
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Most physicians place more weight on the signs they observe, rather 
than relying on patients' disclosure of symptoms. 
Based on his medical experience and education, the physician 
classifies his observations as being normal or abnormal. A symptom 
is usually considered somewhat abnormal since the patient perceives 
it as being different from what is normal for him. But the physician 
must determine if the sign he observes is normal for the patient based 
on his limited knowledge of the patient, as well as his past experi-
ence as to what is normal. Making this situation more complex is 
the fact that signs act very similar to symptoms when it comes to 
variations in severity. For signs such as burns and congestion, the 
variation of severity can be enough to affect the final diagnosis or 
treatment. This makes it essential for the physician to determine an 
often fuzzy or unclear degree of abnorMality for the observed sign. 
A sign profile similar to a symptom profile must also be 
created to give a more detailed description of the specific sign. 
The important detail of this profile, besides the degree of severity 
mentioned above, is the location of the sign. From his observations, 
the physician can usually limit the location to a fairly precise domain 
by either seeing, feeling, or hearing the sign. Other factors such as 
longevity and continuity are also included in this profile. Unfortu-
nately, these aspects have to be disclosed by the patient, unless the 
physician can estimate them based on his observation of the sign's 
progress in development. 
Whereas the preciseness of symptoms is affected by proper 
communication and other factors, the specification of signs depend on 
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proper observation and designation. When questioned, physicians admitted 
that they had incorrectly identified or missed observing many signs. 
Reasons for this included the following: 
1. The observed signs did not warrant 
further investigation. 
2. The physician was inexperienced at the time. 
3. The sign rarely occurred in normal practice. 
4. Observations were restricted to a limited area. 
5. The sign was not significant at the time of observation, 
but became more profound as time progressed. 
Other, more general reasons included error in judgment, misrepresenta-
tion, and incorrect evaluation of the observation. 
During the development of symptom and sign profiles, the 
physician must evaluate each of these attributes, eliminating those 
which do not seem pertinent to the present sickness. Although symptoms 
and signs are abnormal, they may exist in the host patient continually 
and not be associated with the present sickness. Others may be of 
such a nature that they cannot be related to other attributes or any 
disease. These unimportant symptoms and signs should be eliminated to 
discourage wasted additional effort and consideration. 
At the end of this subsystem, the physician must reach an initial 
preliminary diagnosis reflecting the patientts pertinent past history, 
symptoms, and signs. This decision guides the diagnostic reasoning 
process and test selection process, discussed in the following sub-
systems. 
The mathematical representations of this subsystem have been 
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somewhat incomplete and oversimplified in past research. First, very 
little attention has been focused on the physician's proper inter-
pretation of a patient's description of symptoms. Most models begin 
with medically designated signs and sumptoms, which have already been 
evaluated by a physician. More mathematical emphasis should be placed 
on symptom interaction between the physician and patient, to ensure 
more optimal interpretation of the symptoms, as well as their severity. 
The severity of signs and symptoms has often been misrepre-
sented in most diagnostic models. Some past research has indicated 
that the syMptoms and signs are dichotomous [26]. That is, the signs 
and symptoms either exist or do not exist, with no degree of severity 
distinguishable. This aspect definitely affects the preciseness and 
accuracy of these models, since physicians admit that the degree of 
severity of attributes influences their decisions. Other techniques 
used to represent the severity of signs and symptoms are somewhat 
artificially imposed [23]. Included in these techniques are 
assumptions that the severity of a symptom is normally distributed 
about a mean or fits some other continuous distribution. Others impose 
rigidly bound severity categories into which the symptom or sign must 
fall. But symptoms are felt and described by patients with varying 
levels of sensitivity and expression. Thus, their descriptions of 
these terms are too fuzzy and imprecise to be made to fit any dis-
tribution or limited to one of two or three mathematically imposed 
categories whose bounds can, at best, be vague. 
Mathematical techniques used to model the preliminary diag-
nostic decision and the initial hypothesis are discussed in the 
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following section when final diagnostic decision models are enumerated 
and evaluated. 
Diagnostic Reasoning and the Diagnoses  
Once the history and signs have been collected and evaluated, 
explanations for these attributes should be developed by the physician 
via a diagnostic reasoning process. The initial preliminary diagnosis 
of the last subsystem, as well as revisions made in this subsystem, are 
used by the physician to guide steps taken in various phases of this 
reasoning process. 
The process's initial phase usually involves further analysis 
of a specific aspect of the attribute, the location factor. The portion 
of the body that is the attribute's structural or functional source is 
defined to be its domain. This domain may encompass the location of 
more than one structural or functional attribute. Recognition of 
attributes with the same or related domains restricts investigation to a 
more limited physical area. The domain of each attribute can usually 





An organ is a discrete structure, usually consisting of a cover, 
interior lining, and enclosing vessels and ducts. Examples include 
the skin, the brain, the stomach, the lung and the heart. A region  
is more generalized in location than an organ, and pertains to an 
anatomically defined part of the body, containing more than one organ. 
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This category comprises such areas as the abdomen, chest, head and pelvis. 
A channel consists of a group of structures or organs connected in a 
direct anatomic sequence for the functional purpose of transmitting a 
flow from one part of the body to another. The digestive tract, the 
nervous system, and the urinary tract are examples of these channels. 
The system is the last category and differs from the previous three 
types of domains in that it is defined according to its function rather 
than its location. For instance, the endocrine system regulates other 
systems and the cardiovascular-pulmonary system circulates oxygenated 
blood. If a more precise attribute location than the domain is known, 
then the location of the attribute can be classified as a focus within 
that domain. Naturally, attributes such as fatigue or weakness, which 
exhibit no specific location, cannot be placed into the above categories. 
The next phase of the reasoning process involves determining the 
precise effect the causes of the attributes have on their domain. These 
causes may be revealed to a certain degree in the preliminary diagnosis 
of the physician. If there exists a gross abnormality of the domain, 
then a disorder exists. The degree of this disorder is determined from 
the signs, symptoms, severity of signs and symptoms, sign and symptom 
frequency, as well as clinical tests performed for this purpose. A dis-
order of the domain's structure is called a lesion, and, of function, 
a dysfunction. Factors influencing the importance of a lesion include 
size, composition, and location. Factors influencing dysfunctions are 
quantity of function, operation, and direction. It is unlikely that 
these factors can be observed during physical examination of the patient, 
unless the dysfunction or lesion occurs near the surface of an observable 
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domain. If info/illation concerning the precise domain of the attributes, 
the degree of disorder, or other factors of the disorder are not known 
from the physician's observations, selected clinical or diagnostic tests 
may be performed to provide the needed information. Information 
obtained from these tests should be added to the attribute information 
and a revised preliminary diagnosis made. Aspects of this testing 
will be discussed further in the next subsystem. 
Once the disorders and levels of disorders have been established, 
direct effort should be made by the physician to reach an effective 
final diagnosis. The last preliminary diagnosis may be of such a 
nature that no additional information is needed to decide upon the 
final diagnosis. However, if the preliminary diagnosis does not 
designate a specific cause of the attributes with an acceptable level 
of certainty, then other additional information is needed. At this 
point, the physician makes a differential diagnosis. In doing so, he 
selects a group of possible diseases or causes of the attributes from 
his final preliminary diagnosis. Through diagnostic tests or personal 
evaluation, the possible diseases are eliminated until the most likely 
disease candidate or candidates are known. Further tests, if available, 
can be performed for re-enforcement of the correct diagnosis. 
The questionnaire revealed other eseential information about 
this subsystem and the state of the diagnosis. The following per-
centages indicated how often a sick patient's final diagnosis fell into 
the given categories: 
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Single Disease 	 62.8 percent 
Multiple Disease 	 20.0 percent 
A Few Possible Diseases 	 5.7 percent 
No Precise Disease 	 5.7 percent 
Only Known That Certain Diseases 
Do Not Exist 	 5.8 percent 
Almost two-thirds of the diagnoses reached by physicians answering 
this survey limited the possible diagnostic candidates to a single 
disease. One-fifth of the diagnoses designated more than one disease 
present in the host. The remaining categories together accounted for 
a little more than 15 percent of the diagnoses. For one of these cate-
gories, the physician was not able to reach a diagnosis of a specific 
disease entity, so treatment was started aimed at a few possible 
diseases. The last two categories include diagnoses that are less 
precise than the first categories. In one of these, the attributes 
do not correspond to any specific disease entity, thus the disease 
is identified only by these attributes. For the other category, the 
diseases of concern have been eliminated from the possible candidates, 
leaving those lacking in enough severity to demand additional attention. 
The questionnaire results also revealed how often physicians seek 
assistance from other physicians before reaching a diagnosis. Physicians 
consulted one another in approximately the same percentage of cases, 
regardless of the patients location at the office or the hospital. 
No physicians consulted with other physicians for more than 30 percent 
of their cases and the majority consulted for less than ten percent. 
Thus, most of the diagnostic decisions in this subsystem are made by 
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the single physician attending the patient. 
Certain aspects of this diagnostic subsystem have been modelled 
extensively, while others have received relatively little attention. 
Models involving the actual diagnosis decisions (preliminary and final) 
are abundant in decision theory and information science research. These 
models involve pattern classification techniques oriented towards com-
puterized diagnosis and often requiring huge amounts of data not 
readily available. They are also limited to diagnosing single disease 
entities and cannot cope with multiple diseases in the same patient. 
Furthermore, the output of these models rarely determines the diseases' 
stage of development and assumes attribute consistency throughout the 
history of the disease in the patient. 
The two techniques used in the vast majority of these models 
center on cluster analysis or Bayes' optimality criterion (formula). 
Application of BayesT formula [31,39,48] requires a subjectively 
determined a priori probability of each disease, and conditional proba-
bilities for specific symptoms and signs, given a certain disease is 
present. The objective is to find the disease with the maximum 
probability, given that a specific set of attributes exist. If this 
initial probability is not high enough, some sequential models allow 
additional information to be added until the probability reaches a 
certain acceptable level. 
More complex forms of Bayest equation have been applied when 
symptom and sign severity are assumed to be normally distributed. 
A multivariate normal distribution is then used in calculating the 
needed conditional probabilities. Additional complexities arise when 
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the appearance of symptoms and signs are dependent upon one another. 
The error of many Bayesian models is to assume statistical independence 
for the sake of computational simplicity [23]. But the interrelation 
of attribute appearance, location and severity is pertinent to an 
effective diagnosis. To alleviate this problem, complex convariance 
structures, requiring vast data bases or precise subjective probability 
guesses, have been suggested. But often attribute dependency is non-
homogeneous throughout the severity of the attribute, making this 
approach incorrect. Another technique, involving the clustering of 
dependent attributes, has been developed to solve this problem [43]. 
In this method, signs and symptoms within the cluster are dependent 
upon one another, but the clusters themselves are independent. 
Probabilities are then based on the independent clusters rather than on 
individual attributes. Other technique's have been developed to handle 
these dependent attributes, including adjustments on solutions where 
dependency was assumed [42]. 
Perhaps the greatest drawback to Bayesian models representing 
the diagnostic decisions concerns the definitions of the probabilities 
themselves. In these models, the significance of each attribute to 
the disease is determined solely by the percentage of time it is present 
when the disease occurs. But in the actual decisions, this is not the 
only factor influencing the importance of an attribute to a disease. 
A symptom, such as fatigue or weakness, may occur with relatively 
high probability, but its importance to the diagnosis may be small. 
On the other hand, a symptom such as anginal pain or syncope may occur 
with relatively low probability, but its occurrence may be a cardinal 
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or key attribute of the disease. Thus a more fuzzy concept, such as the 
pertinence of the attribute to the disease, may be needed to represent 
attribute significance in the diagnosis decision. 
Many of the difficulties associated with Bayesian models are 
also encountered in the use of cluster analysis techniques [23,26,34]. 
Cluster analysis techniques involve classifying a patient to the proper 
disease by determining differences between the patient's attribute 
vector and attribute vectors for each of the possible diseases. These 
models include classification according to the mean squared error 
criterion, closest neighbor criterion, and least Euclidean distance 
criterion. Most models of this type are oversimplified with respect 
to symptom and sign representation and do not follow the sequential 
nature of the process when modelling preliminary or final diagnoses. 
The significance of the attributes to each of the diseases is often 
omitted and improperly assumed to be constant for all attributes. 
Although past clustering techniques lack development and specificity, 
the possibility for more realistic models lies with the adaptability 
of these methods. 
Unfortunately, few references include any modelling of the 
diagnostic reasoning process described earlier. The models just 
discussed make no attempt to explain the occurrence of attributes, but 
only classify them to reach a diagnosis. As stated by Leroy, "Tradi-
tional principles of science require that natural phenomenon be 
explained, not merely labelled. Scientific connection for relations 
between symptoms and diagnoses is performed by sequential explana-
tions." [37]. Thus, additional modelling efforts need to be initiated 
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in the diagnostic reasoning area to alleviate this deficiency. 
Tests for Additional Information  
The purpose of the previous subsystems was to gain information, 
evaluate this information, and reach the proper diagnoses. At many 
points in this sequential process, improper descriptions, observations, 
and interpretations, as well as omission of information could result 
in an improper diagnosis. Thus, clinical and diagnostic tests are often 
performed throughout the diagnostic subsystem to gain the information 
needed to guarantee a proper diagnosis. These tests involve investi-
gation of body fluids and tissue, as well as the use of electron- 
ically oriented machines that produce such evidence as X-rays or E.C.G. 
A variety of specific interrelated reasons exist for the use of 
diagnostic and clinical tests. Included in these are the following: 
1. Development of information for determining the 
presence or degree of a disorder. 
2. Qualification and quantification of the pertinent 
aspects of lesions and dysfunctions. 
3. Elimination of a disease candidate from consideration 
during the differential diagnosis phase. 
4. Validation of a disease or diseases as the proper final 
diagnosis. 
Rather than perform a test haphazardly, the physician must 
determine if the need for the test outweighs its contraindicants. 
To determine this need, the physician must ask himself: "How important 
can the results of this test be in determining or changing the final 
diagnosis? Will the results of this test provide a better 
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understanding of the disease process in this patient? Will the patient 
benefit from what I am looking for if I find it?" Specific answers to 
these questions reveal the importance or significance of the test result 
to the diagnostic process being carried out. 
Certain factors must be weighed against the test's need to 
determine if the performance of the test is justified. Unfortunately, 
these factors are somewhat fuzzy and difficult to quantify. The 
questionnaire revealed the following as determining factors: 
1. The usefulness or the physician's past success with 
the test. 
2. Danger of the test. 
3. Cost of the test. 
4. Convenience of the test to the patient and physician. 
5. The test's discomfort or pain. 
The first three factors are the most important to physicians 
selecting a test. Certainly the danger factor, as well as the cost 
factor, could overshadow the real need for the test. Another factor 
mentioned by the physicians included their familiarity and understanding 
of the test. This is somewhat incorporated into the physician's past 
success with the test, since he must be familiar with the test to 
determine its success rate. 
Therefore, before a test is performed, it should be evaluated 
with respect to its need versus its usefulness (success), cost, con-
venience, danger, discomfort, and familiarity. If the need does not 
warrant the cost and other negative factors, then the test should 
not be performed. If this evaluation results in more than one 
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favorable test, then the best test should be selected from the 
beneficial candidates. 
The following medical criteria are often used by the physician 
to determine the usefulness or success of these tests: 
1. Sensitivity 
2. Specificity 
3. Predictive Value 
The term sensitivity corresponds to the percentage of positive 
test results in patients actually possessing the disorder or disease 
the test was aimed at. This sensitivity may vary with the develop-
ment of diseases or disorders, since the early stages are frequently 
undetectable. Specificity is derived from the percentage of negative 
results among people who do not have the tested disease or disorder. 
For a test to be useful, both the specificity and the sensitivity 
should be relatively high. The predictive value of a positive test 
result defines the percentage of positive results that are true 
positives. This value varies with the sensitivity, specificity, and 
incidence of the test. If the test is not performed often, then the 
values of specificity and sensitivity may possess a great degree of 
error. Thus, before considering a test of this type, the physician 
should determine whether the test sensitivity, specificity, and pre-
dictive values are adequate to provide clinically useful information. 
Once the best possible test has been selected, the physician, 
laboratory assistant, nurse, or other person performs the test after 
possible preparations. The results of these clinical tests can be 
evaluated with respect to their "degree of abnormality." Test results 
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of this type include blood pressure, leukocyte level, and serum 
cholesterol level. By increasing above or decreasing below the "normal" 
range, the degree of abnormality of the test result increases. On the 
other hand, many tests, primarily those aimed at the final diagnosis, 
are concerned more with dichotomous results. Tests of this type either 
prove or rule out specific patient abnormalities. 
Mathematical models for determining the best possible test at a 
specific time in the diagnostic process have been developed in past 
research. The two methods found while studying for this research include 
the use of decision trees, as well as a single test selection function. 
The decision tree approach [32] is usually incorporated in a model of 
the whole decision process, while the test selection function represents 
only this subsystem. Models of the decision tree type do not seem 
sensitive to all the factors which influence test selection. Also, 
sequential testing cannot be easily handled by this decision tree 
approach without re-evaluation of the tree at each step. The test 
selection itself is often based solely on a priori probabilities, 
since the overall analysis usually starts with test selection, followed 
by diagnosis and treatment selection. Other difficulties, normally 
encountered when using decision trees, are studied later in treatment 
modelling analysis. 
Unlike the decision tree approach, test selection by a single 
function seems more appropriate and representative of the process's 
important factors [41]. Sensitivity, specificity, predictive value, 
and other variables can be incorporated into this test selection 
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function. Sequential testing can also be evaluated with less difficulty, 
since components of each test function usually remain specific and con-
stant for a given test. Consequently, future research needs to be per-
formed in this area to better illustrate the assets of this method. 
The General Treatment Process  
The treatment process begins when the final diagnosis is reached 
in the diagnostic subsystem. Once the physician has explained the 
incidence of signs, symptoms, and other attributes and makes this 
diagnosis, he begins to consider a treatment or therapy for the sickness. 
His treatment decisions normally fall into two classifications - thera-
peutic and environmental. Therapeutic decisions involve the selection 
of the treatment, while environmental decisions are aimed at the 
management of the host during treatment administration. The treatment 
process may last only a short period of time or the rest of the patient's 
life. The length of the process depends upon the effectiveness of the 
treatment and the nature of the disease or disorder present. 
Selection of the Treatment: Therapeutic Decisions  
The category of the final diagnosis directly influences the 
treatment strategy as well as the treatment selection itself. If the 
physician has determined conclusively that a particular single disease 
is present, the best possible treatment for that disease is selected. 
If the physician has designated multiple diseases in the diagnosis, 
then treatment should be aimed at each disease present. Unfortunately, 
one disease' treatment may interfere with the treatment of another, 
creating complications. In this case, the most serious or dangerous 
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disease should be selected and treated initially. When the diagnostic 
process names no specific disease with certainty, then one or more 
diseases of a finite set of possibilities may exist. The usual 
strategy would be to select the treatment for the most likely disease. 
But this treatment could be dangerous to one of the other contingent 
diseases if the most likely candidate does not subsist in the patient. 
Thus treatment consequences must be evaluated in the selection of the 
proper remedy when the diagnosis falls into this category. When no 
precise disease can be designated to explain the attributes, then 
treatment must be based only on these attributes. For sicknesses where 
the physician knows what diseases do not exist, the serious diseases 
have been eliminated from the list of possible candidates. In these 
instances, no treatment or only remedial treatment may be necessary. 
This concludes the strategies for the given diagnosis categories. 
The physician must use this strategy to select a treatment from 





5. Physiotherapy or Physical Therapy 
6. Psychotherapy 
7. Combination of Categories 
8. No Specific Treatment 
The idea behind the treatment process is to repeat, reproduce, and 
surpass past success in remedying similar diagnostic situations. 
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Only rarely is the treatment process creative in nature, since certain 
moral implications as well as legal problems tend to discourage this. 
To select the proper treatment, the physician can study the past 
etiology and pathogenesis of the diseases specified in the diagnosis 
to determine the best medical treatment. Physicians occasionally lack 
information about the patient or the treatment's effect on the patient. 
Thus, clinical tests must be run to determine the appropriateness of 
treatment for a specific patient. 
If more than one treatment is deemed medically effective and 
appropriate, then other factors may influence the selection of the 
best treatment. These factors, somewhat fuzzy in nature, are listed 
below along with their average occurrence in the treatment decision. 
Factor Occurrence 
1. Danger of the treatment Often 
2. Extreme cost of the treatment Often/Occasionally 
3. Desirability of treatment to 
patient Occasionally 
4. Pain of the treatment Occasionally 
5. Physician's success with the 
treatment Occasionally 
6. Time consumption of the treatment Occasionally/Seldom 
7. Unfamiliarity of treatment Occasionally/Seldom 
These influences, as well as the predicted medical effectiveness of 
the treatment, should be weighed against the patient's need for the 
treatment. Criteria for determining this treatment effectiveness and 
need are so similar to those discussed in the test selection subsystem 
that they will be omitted from this phase of the research. Once these 
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factors are evaluated with respect to one another, the proper treatment 
is selected via the treatment strategy. 
Models for analyzing the selection of treatment have been 
developed in detail. These models use, almost exclusively, a decision 
tree approach to the problem [20,32,44]. They are invariably applied 
to problems where some uncertainty exists as to what disease is present. 
This would correspond to the category of "a few possible diseases" in 
the diagnostic subsystem. When using the decision tree approach, the 
selection of treatment depends upon the following information: 
1. A priori probabilities of the diseases being present. 
2. Conditional probabilities of treatment results. 
3. Conditional consequences or utilities given the 
treatment and diseases. 
While the structure of decision trees may assist the physician in 
analyzing his alternatives, the quantitative measures cannot hope to 
be very exact. By the time all the conditional probabilities for a 
very large tree have been determined, variations in quantification could 
give an incorrect treatment selection. The consequences or utilities 
also may vary between physicians since personal ethics and experience 
are subjectively determined by each physician's own personal criteria. 
Any pruning of large decision trees, as suggested in past research, 
may be dangerous since alternatives with very low probabilities could 
have drastic consequences, demanding additional consideration. There-
fore, the decision tree is a good technique for enumerating treatment 
alternatives and consequences, but large data bases may be needed before 
quantitative consistency is attained. 
Another model has been developed to handle a very specialized 
case of the treatment selection process. Developed by Knapp and 
Oeltjen [35], this method uses a benefit-risk ratio to select drugs 
which have potential side affects as well as potential risks. Risk 
interpretation by different physicians is questioned and believed to 
vary somewhat, as was the case in evaluating the utilities used for the 
decision trees. To validate this hypothesis, diseases were graded with 
respect to seriousness. Then physicians weighted each drug, using 
a risk versus need or benefit criterion. The experimental result 
verified that interpretation of risks and benefits varied between 
physicians. 
Treatment of the Patient-Environmental Decisions  
Once the treatment or therapy has been selected, the physician 
explains, prescribes or performs the treatment of choice. The 
physician interacts with the patient, often altering aspects of the 
treatment to meet the patient's needs and desires. In many instances, 
the physician must explain the treatment, the appropriateness of the 
treatment, as well as fuzzy and nonfuzzy instructions for administra-
tion of the treatment. Decisions made during this process are con-
sidered environmental decisions since they involve the management and 
manipulation of the patient. If the treatment involves diet, then the 
patient is instructed in the low fat, low sodium, or other specialized 
diet. When drugs are prescribed, the physician explains their use as 
well as their possible hazards or risk factors. The patient should 
then follow these instructions and observe possible adverse or negative 
reactions to the drugs. If the treatment involves surgery, then the 
patient should be aware of the surgical process and have knowledge of 
its limitations, hazards, and consequences. During radiotherapy, the 
patient has to be advised of the side affects of the treatment as well 
as the degree of possible success. Psychotherapy is a totally inter-
active, questioning process between physician and patient, often 
involving repeated visits, since therapy is performed via verbal 
communication. For some treatments, success or failure may be fairly 
easy to determine. But with psychotherapy, the results may be diffi-
cult to classify into such discrete categories. In this age of 
abundant medications, explanation, and justification for offering 
no treatment may be difficult, especially if the patient has deter-
mined he needs some sort of relief. Thus, each of these various types 
of treatment require uniquely different environmental decisions of the 
physician. 
If time, test results, or continued symptoms and signs reveal 
that the treatment offered is not successful, then additional actions 
and decisions must be made. If the treatment selected was actually 
the best therapeutic treatment, then several reasons could account for 
the unsuccessful result. First of all, the instructions given the 
patient concerning self administration of drugs, physical therapy, or 
diet could have been imprecise, incomplete, or too complex for the 
patient's comprehension. The patient may have been unattentive, 
uncooperative, or apathetic towards listening or abiding by the treat-
ment instructions. Also, an effective treatment for one group of 
patients may be ineffective for another group, since certain aspects 
of the patients' past history and body chemistry vary. An error in 
the actual treatment process, not noticed during treatment application, 
may result in less than optimal results. For instance, psychotherapy 
or specific surgery may be the treatment of choice, but if it is 
administered incorrectly, adverse consequences could occur. 
A treatment could also be ineffective if the physician's treat-
ment selection was not actually the best possible choice. This could 
be due to lack of critical information or just poor judgment. If the 
treatment selection is improper, then either the selection was wrong 
or the diagnosis, on which it was based, was incorrect. Information 
gained while administering the erroneous treatment should give insight 
into this problem. If only the treatment selection was inappropriate, 
then a new treatment should be selected by returning to the previous 
treatment subsystem. If the diagnosis was wrong, then a new final 
diagnosis must be reached via the diagnostic reasoning process, which 
should incorporate any additional information gained. In a general 
systems theory sense, the diagnostic and treatment process could thus 
be cyclic in nature [45], if ineffective treatments and diagnoses 
continued to be selected. 
Constraints by the Environment  
Constraints by the environment encompass a variety of factors 
which evolve outside the physician-patient relationship, but influence 
it directly. Many of these factors act as limitations or guidelines 
for physician 3riented decisions in the relationship. Such constraints 
are derived from the physicians' professional establishment, legal 
and governmental sources, private business, and community resources. 
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Somewhat ill-defined restrictions, involving professional 
ethics, are administered primarily by legal and professional estab-
lishments. These legal and professional standards enumerate and 
assess specific instances of improper practice and poor decision making. 
Professional criticism may include informal conversation or written 
comments and guidance by fellow physicians through prominent publica-
tions. More specific are the legal constraints which are imposed by 
such agencies as the Food and Drug Administration. They tend to deal 
mainly with prohibiting the performance of certain tests and treatments. 
Certain techniques and drugs, deemed unsatisfactory due to possible 
dangerous consequences to patients, have been banned from therapeutic 
consideration in this country. Other related factors include varying 
degrees of control on the fiscal policies of physicians. This involves 
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private insurance corporations and government programs such as Medicare 
and Medicaid, which place bounds or restraints on the patient-physician 
fiscal relationship. Due to the influx of medical malpractice suits 
and increased costs, insurance companies also influence the medically 
oriented decisions made by physicians. Such influence encourages 
incidences of overtesting in reaching a diagnosis and more conserva-
tive treatment selection. 
A community's attitudes and medical resources also affect many 
of the actions and decisions made by local physicians. Abstracted 
from its population, the community as a whole imposes ethical, 
practical, and medical expectations on its physicians. This is demon-
strated by the lack of patients and financial support from a community 
that desires alternate medical care. Another community constraint 
involves medical facilities which are substandard in quality and 
quantity. As mentioned in a previous subsystem, inconveniences of this 
type curb the number of possible tests under consideration and 
eliminate possible treatments from further evaluation. 
CHAPTER III 
THE DIAGNOSTIC DECISION PROCESS: 
A GENERAL PROBLFM FORMULATION 
Since the decision processes analyzed and discussed in the 
previous chapter are complex and abound, emphasis on mathematical 
models incorporating fuzzy set theory has been restricted to specific 
diagnostic decisions. These decisions involve the use of diagnostic 
information and the reaching of effective medical hypotheses, pre-
liminary, and final diagnoses. The primary reason for the selection 
of this decision process centers on the fact that other diagnostic 
decision processes, such as the test selection process and the diag-
nostic reasoning process, hinge on decisions made in the preliminary 
diagnoses and are thus somewhat secondary. An effective general model 
for reaching the various diagnoses must be developed first, so that 
these secondary decision processes might then be integrated into a 
comprehensive overall model of the general diagnostic decision process. 
Furthermore, development of models for treatment decisions would be 
inappropriate at this early modelling stage, since these decisions 
would depend on medical and mathematical information evaluated during 
the diagnostic process. As a result, the mathematical modelling 
illustrated in this chapter pertains to the gathering and evaluating 
of patient information and the incorporation of this information into 
a general diagnosis making model. 
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Consequently, the prominent model of this research deals with 
the decision upon a medical hypothesis, preliminary diagnosis, or final 
diagnosis. Fortunately, the nature and structure of these diagnostic 
decisions are similar, only the information needed is different. There 
are numerous classical techniques used to model these decisions, many 
of which were mentioned and evaluated in the previous chapter. The 
most formidable classification techniques applicable to this modelling 
include Bayesian statistics and cluster analysis. The shortcomings of 
Bayesian techniques, the most prominent method of previous models, were 
detailed in Chapter II. Thus the techniques of cluster analysis have 
been deemed the most satisfactory for this modelling phase. The 
specifics of these techniques, will be delayed until mathematical repre-
sentations of patient information, needed for these decisions, are 
presented. 
Patient Information: Mathematical Representations  
The modelling of the physician's evaluation of patient informa-
tion is given initially, since its mathematical structure is pertinent 
to the formulation of the general diagnosis decision. The information 
under consideration, discussed in Chapter II, can be classified into one 
of the following categories: 
1. Past patient history. 
2. Present symptoms. 
3. Signs observed upon physical examination. 
4. Results of clinical and diagnostic tests. 
The various diagnosis decisions are usually based on more than one of 
these categories. A medical hypothesis requires information from the 
first two categories, an initial preliminary diagnosis requires informa-
tion from the first three categories, and additional preliminary diag-
noses and the final diagnosis usually require information from all 
these categories. The evaluation of information from each of the pre-
ceding categories has been mathematically represented in the subsequent 
sections. 
Past Patient History 
As mentioned previously, certain specific aspects of the patient's 
past history often aid in suggesting possible candidates for preliminary 
diagnoses. Such nonmedical aspects may include an occupation in a 
dangerous chemical environment, the age group with the greatest disease 
susceptibility, or membership in a high incidence group of the popula-
tion. Medical aspects include the patient's past diagnosed diseases 
and disorders, as well as symptoms that were not diagnosed or observed 
by a physician at the time of their occurrence. 
Conventional modelling techniques represent this past history 
in a variety of ways. In Bayesian methods, the physician assigns a 
subjective a priori probability, p(i), for each considered disease i, 
which supposedly reflects this past history. Other methods may omit 
this information entirely. This research attempts to represent past 
history with more clarity and detail, in an effort to remedy the incom-
plete use of information in the above techniques. 
Let N be the set of diseases under consideration for the diag-
noses. For each disease i E N, there exists a finite set, 0 i , of 
prominent history aspects, similar to those mentioned above. This set 
includes nonmedical aspects as well as medical aspects which are 
physician designated diseases or disorders. Let 
n 




n = number of elements in N. 
This set C2 has as its elements all aspects of patient history relevant 
to the diagnoses. Each of these aspects or elements of Q is either 
present or absent from a particular patient's history and is assumed 
to be binary. To represent this, a 1 x m matrix H is created for each 
patient, such that each element of this matrix relates the presence or 
absence of the corresponding element of the set Q. Thus 
H = [h(l) h(2) 	h(m)] 	 (2) 
where 
h(i) E I 
I = [0,11 
m = number of elements in O. 
Complexities of this modelling arise when physicians encounter 
incomplete designations of medical aspects in the patient's history. 
For instance, rheumatic fever or syphilis may be important to the 
diagnoses of valvular heart diseases, but frequently the patient may 




designated. Thus the physician must often determine the presence or 
absence of rheumatic fever or syphilis based on past, undiagnosed 
symptoms. To mathematically convey this, let QA c 0 such that the p 
elements of 0
A  correspond to the p diseases or disorders which might 
be missed or go undiagnosed, where p s m. Consider the p elements of 
and their corresponding elements in the matrix H. Since both the 
set and matrix are finite, the matrix H can be ordered or restructured 
so that its first p entries correspond to the elements of QA . Thus 
H = [h(l) h(2) 	h(p-l) h(p) h(p+l) 	h(m)] . (3) 
From this matrix H, submatrices HA and HB can be formed such that 
H = [HA,HB], where 
HA = [h(l) h(2) 	h(p)] , 	 (4) 
HB = [h(p+l) h(p+2) 	h(m)] . 
The presence or absence of each history aspect in 0A, represented 
in the binary matrix HA, might then be determined from past, undiagnosed 
symptoms and sicknesses. Since not all these past symptoms will be 
recalled by the patient, the physician only considers the "prominent" 
symptoms of past sicknesses. This concept of prominence is somewhat 
fuzzy in nature and can be quantified via fuzzy set theory. Let 13 be 
the set of possible symptoms for past undiagnosed disease j, where 
lsjsp.Thefuzzysete.,containing the "prominent" symptoms of 
past disease j is defined as 
e j = gxij ,u e (xii ))1x ii E Ovu e (x ij ) z cel 
where 
u e (xij ) E [0,1] 
0 s a s 1 
Whenever the physician designates the membership function u 8. 1J 
(x..) of 
symptom x..ij 
 for disease j over a specified level a, the symptom of 0. 
becomesanprominentusymptom.ForcachfuzzYsete.,1 s j s p, con-
struct a matrix V(j), where the elements of V(j) represent the presence 
or absence of x1.313 
 , V x.. E e.. 





k. = number of elements in O. 
The representation, v(i,j), for symptom i of disease j, is binary and 
thus assumed to lack severity levels since the specifics needed for 





If disease j is not designated in the patient's history, but 
symptoms of disease j have existed in the patient's past, then the 
matrix V(j) must be determined. This matrix V(j) is then used to 
complete the patient history matrix H. For a specific patient and 
undiagnosed disease or disorder j, 
f(V(j)) 
V(j) 	 h(j) 
such that 
f(V(j)) E I 
I = 0,1j 
1 s j s p 
Therefore, a vector of symptoms V(j) is mapped (nonfuzzy) into the jth 
element of HA, such that h(j) equals 0 or 1. 
The function f(V(j)) may be very simplistic in nature, or may 
be similar to the function presented as the general diagnoses decision 
model. The number of elements for the sets ^A  and 	 j Py e0 
given as examples later in this research, are relatively few. Thus, 
the simplistic approach to this function, taken for this research, is 
presented in the illustrative example of Chapter IV. Using this mapping, 
the past history matrix HA Can be quantified for all possible elements 
h(j), 1 s j s p. The completed matrix H is then used later when the 
various diagnoses decisions are modelled. 
Present Symptoms  
The interpretation of patient symptoms, as well as the evaluation 
5 2  
of past modelling representations, was discussed at length in Chapter II. 
Each of the past models studied begins the decision process with the 
symptoms already designated or severity levels determined. As was 
mentioned previously, these severity levels are often incorrectly 
assumed to always be binary. Since subsequent modelling of this 
research attempts to determine the presence of a disease as well as its 
stage of development, the preciseness of these symptom severity levels 
becomes increasingly significant. Medical designation of these levels 
should not be given outright, as in previous models, but should come 
directly from information related by the patient concerning his present 
medical problems. By using the latter approach, the severity levels of 
symptoms can be more precisely defined and designated. 
Tobeginthisphaseofmodelling,letrequal the set of possible 
problems that might be observed or experienced by a patient with disease 
i, where i E N. 
Define 
n 




n = number of elements in N. 
This set 11 comprises the patient related problems that are encountered 
for all diseases under consideration. The elements of this set are not 
medically designated symptoms, but are patient descriptions such as 
dizziness, chest pain, and inability to breathe properly. Associated 
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with each of these problems q, q E flj is a set of factors dq, which are 
important to the medical designation and severity determination of 
problem q. Elements of fig make up what was called in Chapter II the 
undesignated symptom profile or problem profile. Each problem profile 
set Lvl may have the following subsets of discrete information: 
= {location of problem q} 
Lq2 = {longevity of problem q} 
Lq3 = {continuity of problem q} 	
(9) 
Aq4 = {defining aspects of intermittent problem q} 
Aq5 = [ specifics for severity determination of problem q - 
fuzzy descriptions] 
where 
aq = Lql U Aq2 U Aq3 U Lq4 U 6q5 
Let 
r 





r = number of problems in set II 
If 0 is the collective set of medically designated symptoms for the 
diseases under consideration, then 
5 11. 
When determining the presence or absence of a medically designated 
symptom of 0, this mapping is usually nonfuzzy in nature. But when 
the severity level of an element of 13 must be determined, then fuzzy 
sets are often involved in the mapping. 
At this point in the modelling, matrix representations for the 
sets under discussion are introduced. Information obtained from the 
patient with regard to his problems, II, and problem profiles Aq are 
incorporated into the matrix B, defined as 
b(1,1) b(1,2) b(l,r) 
b(2,1) b(2,2) b(2,r) 
B = • (12 ) 
b(s,l) b(s,2) b(s,r) 
An entry of this matrix is denoted by 
b(i,j) 	 (13) 
where 
i E I 
j = 
I = the index for characteristics of the problem profile 
r = max I 
For example, the ith row of this matrix might correspond to the location 
of problems j, j = 1,2,...,r. The jth column of this matrix corresponds 
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to the profile factors in the set LA where j = q. 
This matrix B should contain all the pertinent information 
obtained from the verbal physician-patient interaction during the 
initial interview. Once the information for B has been gained, the 
physician must medically designate the symptoms as well as the severity 
levels. From the set t3 of all possible medically designated symptoms 
under consideration, construct a matrix A such that 
A = [a(1) a(2) 	a(t)] 	 (14) 
where 
a(i) E [0,1] 
t = the number. of elements in S. 
The variable a(i) of A represents the severity of symptom i, with iE 







	0, if symptom i is not related by the patient 
1, otherwise 
Otherwise, the severity of the symptom is considered to be pertinent 
information and can be represented as a(i) E [0,1]. As a(i) approaches 
1, the severity of symptom i increases, while the severity of symptom i 
decreases as a(i) approaches O. 
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The previous mapping (11) of patient-related problem to 
medically designated symptoms can now be more precisely written in the 
matrix form as 
6(B) 
B 	k A (16) 
In this matrix form one problem j may be mapped into one or more entries 
of A. Let b(j) denote a column vector of matrix B. As stated previ-
ously, this vector represents the problem j and the problem profile set 
Pj. The above mapping (15) can now be more specifically written as 
6( -3 (j)) 




j = 1,2,...,r 
i = 1,2,3,...,t 
When a(i) is binary, then 6( -6(j)) E {0,1}. For this case, the function 
8 is very simplistic and usually incorporates the presence or absence 
of a few factors, primarily those of location, in the problem profile. 
If a(i) is not assumed to be binary, then more complex mappings 
involving fuzzy set theory exist. In this case, a component of b(j), 
say b(i,j), often represents the membership function for a fuzzy 
description of the severity of problem j. In this case 
uA(c) = b(i,j) 	 (18) 
where 
c = relative measure or description of the symptom severity. 
A = fuzzy set evaluating severity descriptions. 
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The membership function may reflect the painfulness or blueness of 
symptoms such as headache and cyanosis. Fuzzy sets such as these are 
pertinent to determination of symptom severity levels. Thus for this 
problem case, the function of the mapping in equation (17) becomes 
5(171)( j) ) = 8[b(1,j) b(2,j) 	u(c) 	b(k,j)jT • 	(19) 
This mapping can thus involve functions of fuzzy and nonfuzzy sets. 
Many times, only the membership function of a fuzzy set, uA(c), is 
needed to determine the severity of a symptom. In the example in the 
next chapter, the function frequently is 
6(;(J ) ) =uA ( c) 	 (20) 
or 
6(;(J)) = ( 	(c)) 
where g is a simple function of fuzzy sets and other problem factors. 
Thus, fuzzy set theory is very useftil in determining the severity 
levels of non-binary symptoms. Detailed examples will be given in 
Chapter IV to clarify this theory and to illustrate the specific fuzzy 
sets, their membership functions, and their corresponding functions 
6(b0))• 
Signs Observed Upon Physical Examination  
Signs are observed, evaluated, and designated by the physician 
upon physical examination of the patient. Upon careful inspection, 
the physician determines which signs are present or absent, as well as 
the signs' levels of severity. The modelling difficulties arise in 
determining the severity of the sign in such a way as to correspond 
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to other modelling in this research. Past or previous modelling 
representations of signs are the same as for symptoms. Thus, most of 
these models assume signs are dichotomous, while relatively few reflect 
degrees of severity. This section of research attempts correct this 
deficiency by more precisely modelling varying levels of sign severity. 
For the diseases under consideration, let 
{signs of disease j1 
where 





Consider now the use of matrix notation to represent this information. 
Suppose 
S = Es(1) s(2) 	s(f)] 	 (22) 
where 
f = number of elements in 
s(j) E [0 , 1 ] 	j = 1 , 2 ,...,f 
Thus, s(j) reflects the severity of sign j in the patient. If the sign 
corresponding to s(j) is assumed to be binary then s(j) E [0,1). 
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If severity levels of the sign are pertinent to the various 
diagnoses, then s(j) is nonbinary and s(j) E [0,1]. For each nonbinary 
sign j, there exists a finite set of observable factors or observables, 
which assist in determining the level of severity for the specific sign. 
These observables make up what was termed to sign profile in Chapter II. 
Included in these observables are the locations of the signs and certain 
severity specifics. Rather than have a physician subjectively determine 
the level of severity of sign j, s(j), the use of a model incorporating 
these observables to attain this is proposed. 
Let D denote a matrix of observables, such that 
d(1,1) d(1,2) d(1,f) 
d(2,1) d(2,2) d(2,f) 
D = (23) 
d(e,l) d(e,2) d(e,f) 
with 
e = number of elements in largest set of observables. 





i E I, j = 1,2,...,f, and I = index for each set of observables. 
6o 
Each column of matrix D, say a(j), corresponds to the set of observables 
for sign j. To obtain the severity of sign j, 
tg 	) ) 
d(j)  	s(j) . (25) 
This mapping, as was the case in determining symptom severity, may or 
may not involve fuzzy sets. The function * is usually very similar in 
nature to the function 8 used to map patient information into symptoms 
in equation (17). Nonfuzzy mappings exist when only location factors 
are pertinent to severity determination. If other factors exist, they 
often involve the use of fuzzy sets. For example, severity aspects of 
a systolic heart murmur may involve fuzzy sets with regard to the loud-
ness and quality of the sound. Specific functional relationships of 
111(d(j)) are omitted since the general structures are similar to those 
presented in equations (19) and (20) in the symptom modelling section. 
Results of Clinical and Diagnostic Tests  
The information gained from clinical and diagnostic tests is of 
extreme importance to the final diagnoses. This phase of research 
attempts to represent test results in the same framework as previous 
information, in an effort to incorporate them into the subsequent 
diagnosis model. Very few if any of previous diagnosis models have 
ever attempted to incorporate results from tests in their structure. 
The following model is presented in an effort to remedy this situation. 
Consider the set, Tt, of possible test results of test t. This 
set Tt may be a set of discrete or continuous elements. Fuzzy set 
theory is introduced in an attempt to transform these test results 
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into a proper perspective and scale. For each test t, a fuzzy set Ft 
is created to represent the "abnormality" of the possible test results, 
Tt . The membership function, reflecting the degree of abnormality, 
must be determined for each set Ft, t = 1,2,...,k, and k equals the 
number of tests performed on the patient. Let r t 6 Tt . The degree of 
abnormality of this test result is reflected by the membership function 









z(t) 6 [0,1] 
For the k tests performed on a given patient, let 
Z = [z(1) z(2) ... z(k)] 
represent the test results evaluated via fuzzy set theory. Any test 
result can be mapped into the [0,1] continuum using this theory, so k 
is the number of tests performed. 
For a certain group of tests, the results end in a single 
quantified measure, making it less difficult to determine the 
appropriate membership function. For example, the test performed to 
determine the serum cholesterol level of a patient results in a reading 
expressed in milligrams per 100 milliliters of serum. The degree of 
membership is thus a function of a single variable, where 
(26)  
(27)  
, for rt 
< 260 
ur (rt ) = 	
3150 - 6 , for 260 s rt s 600 
1 	, for rt > 600 
would be appropriate linear function for the fuzzy set of "abnormal" 
cholesterol levels. Similarly, many other membership functions for 
specific tests may be derived from single measurable results of the 
tests. 
Other test results are not as simple, since more than one aspect 
is needed to determine their degrees of abnormality. The result of 
test t, rt, may possess n defining aspects, so that 
rt = Lrt , rt , rt ,...,rt 	 (29) 
1 	2 	3 
where each rt 
, j = 1,2,...,n, is a defining aspect. Thus, the fuzzy 







Y°.., rt ) 
n 
z(t) 	, ( 30) 
where u
rt 
is a membership function mapping r t , r t ,...,rt into [0,1]. 
1 	2 
Since these aspects, r t , j = 1,2,...,n, are very specific to the 
individual test t, generalities concerning the possible structure of 
u (r , r ,...,rt ) are difficult to make. Consequently, this will 
rt t1 t2 







Summary of Mathematical Representations  
The previous sections have given mathematical representations 
for each category of information needed in the various diagnoses 
decisions. A summary of the final representations, needed in the next 
modelling stage, is now presented. 
The past patient history is represented by a binary 1 x m matrix 
H where 
H = [h(1) h(2) 	h(m)] 	 (31) 
and m = total number of designated aspects of past history relevant to 
the diseases under consideration. 
Furthermore 
h(i) E T0,11 	 (32) 
with 
1, if history aspect i, is present 
h(i) = 
0, otherwise 
The 1 x t matrix A represents all the medically designated symptoms for 
the possible diseases. 




a(i) E [0,1] 
t = total number of designated symptoms for all diseases. 
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For the signs observed by the physician, the 1 x f matrix S represents 
the signs under consideration. 
S = [s(1) s(2) 	s(f)] 	 (34) 
where 
f = total number of possible signs. 
and 
s(i) E [0,1] 
The last information category involves results of clinical and diagnostic 
tests. The final mathematical representation of these results is 
designated by the 1 x k matrix Z. 
where 
and 
Z = [z(1) z(2) 	z(k)] 
k = number of tests performed on patient 
z(i) E [0,1] 
( 35 ) 
For the various diagnoses under consideration, the following 
information matrices are needed: 
Medical Hypothesis - [H,A} 
Initial Preliminary Diagnosis - fH,A,S1 
Other Preliminary Diagnosis - fH,A,S,Z1 
and 
Final Diagnosis - [H,A,S,Z1 
65 
Note that the matrix Z increases in size as additional tests are 
performed. The general diagnosis model incorporating these matrices 
of information in specific diagnosis decisions is developed in the 
subsequent section. 
The Diagnosis Decision Model 
General 
The objective of the diagnosis decision model is to assign a 
patient, possessing information matrices H,A,S or Z to a stage of a 
specific disease or a group of diseases. These matrices represent the 
medically designated stage space of the patient. The earlier pre-
liminary diagnoses tend to be aimed at selecting a group of possible 
diseases or eliminating diseases from consideration. The later 
diagnoses are aimed more at naming a single or a few diseases, existing 
at a specific stage of development. For any of these diagnoses, the 
information matrices of the patient must be compared to similar matrices 
for the stages of the possible diseases. The patient is grouped or 
clustered with the stage of disease which is the "closest" or "most 
similar". As was stated earlier, techniques of cluster analysis are 
used to mathematically analyze this patient - disease stage comparison. 
The patient's history matrix, H, must be compared to the binary 
history matrix H(i) of each, disease i. The history matrix for a given 
disease is constant, regardless of the disease's stage of development. 
Thus 




h(i,k)E f0, 11 , 	i E N 
and 
m = number of history aspects. 
The element h(i,k) takes on a value of 1 if history aspect k has ever 
influenced the occurrence of disease i in the patient, and 0 if not. 
The matrix A of present patient symptoms has to be compared to 
each symptom matrix of disease i at its development stages. In order 
to simplify the notation in this and the following sections, the finite 
number of possible diseases i at their finite number of development 
stages are numbered sequentially, j = 	 where g equals the 
total number of development stages for all diseases under consideration. 
The matrix A(j) thus contains the symptom severity specifics needed to 
reflect disease stage j. This matrix numerically designates the upper 
and lower bounds of the symptom's normal range of severity for a given 
stage. Thus 
alb(j,l) alb(j,2) 	alb(j,t) 
aub(j,l) aub(j,2) 	aub(j,t) 
where 
alb(j,k) = lower bound of kth symptom for disease stage j, 
aub(j,k) = upper bound of kth symptom for disease stage j, 
t = number of possible symptoms, 
alb(j,k) E [0,1] 




alb(j,k) s aub(j,k) 
When symptom k is assumed dichotomous or binary, then 
alb(j,k) = aub(j,k) 
alb(j,k) E [0,11 
If symptom k is not dichotomous, then an interval of severity may exist 
for the symptom at a disease stage j. The bounds of this interval are 
derived from the same specifics used to determine a patient's symptom 
severity, a(k). 
A patient's information matrix, S, of observed signs, must be 
similarly compared to sign matrices S(j) for disease stage j. The 




slb(j,k) = lower bound of kth sign for disease stage j, 
sub(j,k) = upper bound of kth sign for disease stage j, 
f = number of possible signs, 
slb(j,k) E [0,1] 
sub(j,k) E [0,1] 
slb(j,k) s sub(j,k) 
As was the case with symptoms, a dichotomous sign k is assumed to have 





slb(j,k) = sub(j,k) 
slb(j,k) E f0,11 
	
40) 
If the sign k is not dichotomous, then a interval of severity may exist 
for the sign at disease stage j. The bounds of this interval are derived 
from the same specifics used to determine a patient's sign severity, 
s(k). 
The expandible matrix Z of patient test results has to be com-
pared to the expected range of test results for a disease at a given 
stage. As was with symptoms and signs, a lower and upper bound for the 
evaluated test results must be known for each disease stage. 
Let 
   
Z(j) = 
z 1b(j , 1) z 1b(j,2)...z1b(j,k ) 
zub(j,l) zub(j,2)...zub(j,k) 
( id ) 
   
   
where 
zlb(j,t) = expected lower bound of test result t for disease 
stage j, 
zub(j,t) = expected upper bound for test result t for disease 
stage j, 
k = number of tests performed on the patient, 
zlb(j,t) 0 [0,1] 
zub(j,t) E [0,1] 
zlb(j,t) s zub(j,t) 
For a given stage of disease development j, the interval of expected 
test results may be in the normal range. In this case, 
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zlb(j,t) = zub(j,t) = 0 
	
(42) 
Otherwise, the upper limit of test result t, zub(j,t) is greater than 0, 
creating a range for test values where 
zlb(j,t) < zub(j,t) 
	
( 43) 
Whereas the matrices H,A,S,Z represent the patient's information, 
the matrices H(i), A(j), S(j) and Z(j) represent the physician's 
knowledge of similar information relevant to disease i or disease 
stage j. 
The Decision Model 
The general objective of cluster analysis is to group similar 
data or variables into clusters. This is a sequential process, involving 
pairwise grouping of variables or'clusters of variables. This clustering 
can continue until all data or variables are contained in the same 
overall cluster or can be designated to stop at a certain number of 
clusters. The cluster analysis used for this modelling is very con-
trolled in that only a single grouping, involving a certain variable, 
is needed. This variable, a diseased patient, must be clustered with 
a specific disease at a given stage. 
Applications of cluster analysis center on the formulation of a 
similarity matrix, Y, for the variables under consideration. In our 
research, these variables are the patient's sickness and the disease 
stage j,j = 1,2,...,g. The similarity matrix Y is a lower triangular 




Y41 Y42 Y43 
Y (hli) 
Yn1 Yn2 "' Yn(n-1) 
where 
y.. = similarity measure between disease stage i and 
disease stage j 
total number of disease stages for all possible 
diseases plus 1. 
The entities i and j of y.., where 1 s i s n- 1, 1 s j s n- 1, 
ij 
correspond to stages of the possible diseases. The entities i and j, 
where i = j = n, correspond to the patient's sickness or disease. Thus, 
the nth row or the last row of similarity matrix Y designates the simi-
larity between the patient's sickness and possible diseases at each of 
their stages. The most similar entry in this row corresponds to the 
disease stage the patient is most likely to have. 
Thesimilaritymeasureyn
.between the patient's sickness and 
the possible diseases must be selected. The two most appropriate 
mathematical techniques include representation of these similarities 
using Minkowski metric distances and product moment correlation coeffi-
cients. Both of these are common similarity measures in cluster 
analysis theory. Of these, the Minkowski distance representation was 
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selected as the most appropriate technique for this research. This 
metric measurement permits the employment of the information contained 
in the matrices discussed in the previous sections. The Minkowski metric 
can be easily modified to incorporate symptom, sign, and test result 
severity bounds, as wellas attribute - disease weighting. On the 
other hand, the correlation coefficient technique cannot handle the 
information of attributes possessing bounded severity intervals. Also, 
the disease-attribute weighting is not as intuitive in this latter 
method. Thus, the use of correlation coefficients as similarity 
measures has been deemed an alternate secondary approach to this 
problem. 
The general Minkowski metric distance between a 1 x m patient 
information matrix X
n 
and information matrix X(j) of disease or disease 
stage j is 
m 
Dp(X(j), Xn) = C v (x(j,k) - xn(k)1 11 1/p 	 (45) 
k=1 
where 
p z 1 , 
m = number of attributes under consideration, 
xn
(k) = representation of attribute k in the patient, 
x(j,k) = representation of attribute k for disease or 
disease stage j, 
xn(k) E [0,1] , 
and 	x(j,k) E [0,1] 
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Since xn(k) represents attribute k of the patient's sickness, it always 
takes on a single value. The variable x(j,k) may represent an aspect 
of history, a symptom, a sign, or a test result of disease or disease 
stage j. If this variable is dichotomous, then the formulation of 
equation (45) is adequate to handle all possible cases of attribute 
absence or presence. But often x(j,k) represents nonbinary attributes. 
The value associated with this variable might then be an interval of 
severity rather than a single measure. For these instances, let 
[xlb(j,k), xub(j,k)] represent the severity interval of variable 
x(j,k). 
Consider the following cases where x(j,k) is represented as a 
bounded interval of severity. If 
xlb(j,k) s xn(k) s xub(j,k) , 	 (46) 
then the patient's attribute is in the interval of severity for disease 
stage j. For this case, 
x(j,k) - xn(k) = xlb(j,k) - xn (k) = xub(j,k) - xn(k) = 0 . (47) 
Suppose the patient's attribute k lies outside the interval of severity 
for disease stage j. If xn(k) < xlb(j,k) then x(j,k) - xn (k) of equation 
(45) becomes xlb(j,k) - x n(k). If xn(k) > xub(j,k), then x(j,k) - xn (k) 
of equation (45) becomes xub(j,k) - xn(k). The following sets can be 
constructed to assist in representing the dichotomous and non-dichotomous 
attribute comparisons for disease stage j. Let 
C j = 
F. = 
Gj = 
fkix(j,k) E (0,11, xn(k) E {0,11, 1 s k 5 ml 
fklxn(k) < xtb(j,k), 1 s k 5 ml 




Equation (45) can now be written as 
Dp (X(j), X n ) = 	lx(j,k) - xn(k)I P 
k E C 
+ 	L,, 	lx1b(j,k) - xn (k)I P 
k E F. 
d /p 
ixub( j ,k) - xn (k) 
k E G. 
In this diagnosis decision process, attribute k of disease or 
disease stage j has a specific weight of importance to the diagnosis 
of that disease or disease stage. This fuzzy concept was termed the 
"pertinence" of attribute k to the diagnosis of disease or disease 
stage j in Chapter II. Let T be the set of attributes under considera-
tion for the diagnoses. Construct a fuzzy set, t j , where t equals the 
set of "pertinent" attributes of disease j. The membership function of 
this fuzzy set determines the weight associated with attribute k for 
disease or disease stage j. Thus u s,.(k) = w(j,k) where w(j,k) is an j 
entry in a n x m matrix W of weights. Thus 
u (T) 




By choosing various values of p, different metric distance 
functions can be obtained from the Minkowski metric equation. In this 
study, the familiar Euclidean distance measure is formed by setting 
p = 2. 
By incorporating weights and the Euclidean distance assumption 
into equation (49), the revised Minkowski metric becomes 
D2 (X(j), Xn) = 	lw(j,k) (x(j,k) - xn (k))I 2 
k E C. 
+ 	lw(j,k) (xlb(j,k) - xn (k))I
2 
k E F. 
1/2 
+ j: 	lw(j,k) (xub(j,k) - xn(k))1 2 1 	(51) 
k E G. 
where 
w(j,k) E [0,1] 
xub(j,k) E [0,1] 
xlb(j,k) E [0,1] 
xn(k) E [0,1] 
x(j,k) E {0,11 
This measure of similarity 
D2 (X(j), Xn ) =. Yjn 
(52) 
of the similarity matrix Y. The minimum revised Minkowski metric for 
the disease stages under consideration reflects the most similar 
75 
disease - patient pair. The objective of the diagnosis decision is to 
minimize D2(X(j),Xn
), j = 1,2,3,...,n 
	
(53) 
Equation (51) is thus the general diagnosis decision model for this 
study. 
The matrices presented earlier in this chapter are easily 
incorporated into this general diagnosis equation to determine the 
various diagnoses. For a decision upon a medical hypothesis, 
D2 (X(j), Xn ) = L (H(i), H) 	D2(A(j),A) 
where 
j E {possible disease stages} 
i E {possible diseases} 
For the initial preliminary diagnoses, 
D2 (X(j) ,Xn ) = D2 (H(i),H) 	D2(A(j),A) 	D2(S(j),S) 
	
(55) 
The metric distance structure for other preliminary and final diagnoses 
i s 







Thus, these various diagnoses are simple to determine due to the 
organization of the data structure. 
By minimizing the function D2 (X(j),Xn ), the best candidate for 
the diagnosis is found. As was previously stated, the earlier diagnoses 
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may limit the diseases to a group of possibilities or just eliminate 
certain candidates. Therefore, the k smallest entries in the last row 
of the similarity matrix Y gives the set P of the k most likely diseases 
to be present. Another possible technique for determining a set P of the 
most likely diseases is to set a threshold value,h, such that 
P = NID2(X(J),Xn ) s h, h > 0} 
	
(57) 
The desired strategy must be selected for the situation under considera-
tion. 
This chapter has developed abstract mathematical formulations of 
the various aspects of the diagnosis decision process. Illustrations 
and examples of this modelling will be presented in Chapters IV and V. 
CHAPTER IV 
MODELLING A DIAGNOSIS DECISION PROCESS: 
AN INSTRUCTIVE EXAMPTE  
The model development of Chapter III would be somewhat incomplete 
if an instructive example of the information structures and the diag-
nosis model were not given. Due to the vast amount of medical know-
ledge and the data required for a model of the complete process, the 
example herein is concerned only with reaching a medical hypothesis 
as to which disease is present in the patient. The patient information 
needed for this example includes the patient's past history and present 
symptoms of his sickness. The diseases under consideration for this 
medical hypothesis have been limited to rheumatic valvular heart 
diseases. Even for this very specialized area of medicine, the 
possible information structures needed to reach a final diagnosis 
would be immense, making an earlier diagnosis decision the only 
feasible one for this research. 
The information and data used for this example were obtained 
from prominent medical references and were evaluated and supplemented 
as appropriate by local physicians. Since large amounts of actual 
patient information were not available for this research, the data 
presented often tends to be subjective in nature. As a result, the 
following exemplification is representative of the actual process from 
the viewpoint of a limited number of physicians used as well as per-
tinent references from medical literature. 
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Example of a Hypothesis Decision Process  
General 
In the example given here, the patient's sickness may be 
clustered with one of five possible diseases at one of three disease 
development stages. Therefore there are 15 stages of diseases or 
disease variables that can be paired with the patient's sickness. 
The five rheumatic valvular diseases are as follows: 
1. Aortic insufficiency 
2. Aortic stenosis 
3. Mitral insufficiency 
4. Mitral stenosis 
5. Tricuspid insufficiency 
All of these diseases are related in that they are concerned with 
malfunctions around the valve areas of the heart, frequently causing 
heart failure. Each disease is assumed to have three stages of 
development - early, intermediate, and late. Although these are not 
naturally disjoint categories, medical reasons involving the size of 
the valve openings warrant such divisions. 
Relevant Past History 
There are relatively few aspects of patient's past history which 
are relevant to the diagnoses of rheumatic valvular heart diseases. 
These aspects, which make up the set Q in Chapter III, are listed in 
Table 1. The nonmedical aspects, including sex and age, are important 
to many diagnoses and thus should always be given consideration. The 
medical aspects are made up of diseases which directly cause valvular 
heart disease. These include rheumatic fever and syphilis. Other 
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causes of these diseases, such as atherosclerosis, exist, but do not 
show up in the patient's past history. 
Often the patient might have had rheumatic fever or syphilis, 
but it went unobserved by a physician and thus was not medically diag- 
nosed e created 
and contain "prominent" symptoms of rheumatic fever and syphilis. These 
sets are shown in Table 2. Note that each of these sets only contains 
two elements. The binary matrix V(j), representing the presence or 
absence of the elements of Oj ,must be mapped into the patient history 






f( V(j)) E 10, 11 
In this example V(j), for j = 1, 2, are only 1 x 2 matrices, allowing 
the function f to be very simplistic in nature. If both the symptoms 
ofej . are present in the patient's past history, then the disease j is 
assumed present and h(j) = 1. Thus 
1 if V(j) = [1,1] 
f(V(j)) = { 
The past history of the patient can then be incorporated into a 
1 x 8 binary matrix, H, which denotes the presence or absence of the 
history aspects in Table 1. This history matrix must be compared to 
the binary history matrix H(i), for each of the five diseases, 
(59) 
0, otherwise 
Table 1. Relevant Aspects of the Patient's Past History. 
Medical Nonmedical 
Diseases Sex 
1. Rheumatic fever 4. Male 
2. Syphilis 5. Female 
3. None of these diseases Age 
6. Young (Under 30) 
7. Middle Age (30-60) 
8. Old (Over 60) 
Table 2. Prominent Symptoms for Past Undiagnosed Diseases. 
Rheumatic Fever (j=1) 	 Syphilis (j=2) 
1. High fever 	 3. Pinkish skin rash 
2. Sore, sensitive joints 	4. Pronounced sores 
8o 
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i = 1,2,...,5. Past history is dependent upon the disease and not the 
stage of the disease, so 15 matrices are not needed. The history 
matrices for each of the diseases are given in Table 3. They are very 
similar to one another, since the disease area under consideration is 
restricted. The medical aspects of the matrix take on a unit value if 
the past disease relates to the valvular disease, a zero value if not. 
The nonmedical aspects for these diseases are all present to some degree 
in past cases of valvular heart diseases, giving all of them a unit 
value. The similarities between these matrices and the patient's matrix 
must be determined. The weights, w(i,k), associated with the importance 
of history aspect k to disease i are given in Table 4. These weights 
reflect the percentage of time the history aspect k has been present in 
a patient with disease i [2]. If history aspect k does not influence 
disease i, i.e. h(i,k) = 0, then w(i,k) takes on a negative unit value. 
By incorporating these weights into equation (51), the similarity 
measure D2 (H(i), H), i = 1,2,...,5, can be determined. Thus 
8 	 1/2 
D2 (H(i),H) . 	lw(i,k) (h(i,k) - h(k))1 2 ] 	, 	 (6o) 
k=1 
i = 1,2,...,5 
These values are used later to determine the hypothesis decisions. 
Present Symptoms of the Diseases  
The other collection of information needed to reach a medical 
hypothesis pertains to patient related problems that are transformed into 
medically designated symptoms of valvular heart disease. The set of 
patient problem areas II, relevant to these diseases, is given in Table 5. 
Table 3. Binary Matrices of Past Patient History. 
Disease i 	 Disease History Vector-H(i) 
k= 1 2 3 4 5 6 7 8 
1. Aortic Insufficiency 1 1 1 1 1 1 1 1 
2. Aortic Stenosis 1 0 1 1 1 1 1 1 
3. Mitral Insufficiency 1 0 1 1 1 1 1 1 
4. Mitral Stenosis 1 0 1 1 1 1 1 1 
5. Tricuspid Insufficiency 1 0 1 1 1 1 1 1 
Note: k denotes history aspect number from Table 1. 




2 	3 	4 	5 6 7 8 
1. Aortic Insufficiency .6 .2 .2 .7 .3 .2 .7 .1 
2. Aortic Stenosis .7 -1 .3 .7 .3 .2 .7 .1 
3. Mitral Insufficiency .6 -1 .4 .6 .4 .3 .6 .1 
4. Mitral Stenosis .6 -1 .4 .2 .8 .3 .6 .1 
5. Tricuspid Insufficiency .6 -1 .4 .4 .6 .3 .6 .1 
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For each of these problem areas, there is one or more corresponding 
medical symptoms. The designated symptoms of rheumatic valvular heart 
disease, f3, are given in Table 6. The definitions of these symptoms, 
as well as factors influencing their severity, are given in Appendix B. 
Two purposes for the previous mathematical model were to map the 
problems of Table 5 into the symptoms of Table 6 and to determine the 
severity levels of these symptoms. The information needed to achieve 
this must be obtained from the patient and incorporated into a profile, 
, for each problem q. The profile categories needed for this example 
are as follows: 
1. Location of the problem, 
2. Continuity of the problem, 
3. Activities accompanying symptom occurrence, 
and 	 4. Specifics for severity determination (fUzzy sets). 
Table 7 gives a complete listing of the specific factors for each of 
these categories. Therefore, for each problem communicated by the 
patient, the listed factors assist in determining the symptom and the 
symptom's level of severity. Numbers associated with each of these 
factors, found in Table 7, are placed in the appropriate factor rows 
and problem columns of the matrix B, defined in equation (12). 
For this exemplification, the profile matrix B is a 10 x 15 
matrix. 
B = [b(i,j)j , 	i = 1,2,...,10 	 (61) 
j = 1,2,...,15 
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Table 5. 	Patient Related Problem Areas. 
1. Breathing difficulty; 9. Dizziness; Lightheadedness; 
Shortness of breath Confusion; Greying out; 
Unconsciousness 
2. Coughing 
10. Irregular heartbeat 
3. Blood in sputum 
11. Pain 
4. Purple skin color 
12. Swelling 
5. Red face and lips 
13. Weight gain 
6. Yellow skin color 
14. Appetite loss 
7. Weakness; Lack of energy 
15. Nausea and Vomiting 
8. Fatigue; Tiredness 
Table 6. Medically Designated Symptom. 
1. Exertional Dyspnea 11. Palpitations 
2. Paroxysmal Nocturnal Dyspnea 12. Typical Anginal Pain 
3. Cough 13. Epigastric Anginal Pain 
4. Hemoptsis 14. Pain from Enlarged Liver 
5. Cyanosis 15. Headaches 
6. Malar Flush 16. Peripheral Edema 
7. Jaundice 17. Ascites 
8. Weakness 18. Weight Gain from Edema 
9. Fatigue 19. Anorexia 
10. Syncope 20. Nausea and Vomiting 
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Table 7. 	Factors of Problem and Symptom Profiles. 
Location Factors 
1. Fingernails 9. Lower chest 
2. Face 10. Middle chest 
3. Lips 11. Inner left arm 
4. Ankles 12. Arms 
5. Feet 13. Back of Neck 
6. Legs 14. Head 
7. Abdomen 15. Back 
8. Upper abdomen 
Continuity Factors 
1. Continuous 2. Intermittent 
Activities Provoking or Accompanying 
Intermittent , Symptom Occurrence 
1. Running 6. Resting 
2. Climbing stairs 7. Recumbency 
3. Lifting heavy weight 8. Sleep 
4. Walking 
5. Standing from sitting position 
Specifics for Severity Determination 
1. Productivity of cough 5. Purpleness of Skin 
2. Painfulness of Headache 6. Awareness of patient 
3. Bloodiness of Sputum 
4. Increasing weight 
where in (61), 
0 if problem j is present 
b(i,j) 
1 if problem j is absent 
b(2,j) E [0,1] (Severity specifics for problem j-fuzzy sets) 
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b(3,j) = 
I 1 if problem j is continuous 
2 if problem j is intermittent 
b(4,j), E (Activities accompanying problem j occurrence} 
b(6,j) 
E [Locations of problem j} 
b(10,j) 
Before determining the level of a symptom, the symptom itself 
must be designated based on the problem and problem profile. For 
valvular heart disease, the greatest amount of information needed to 
do this includes the problem, the locations of the problem, and the 
activity accompanying the problem occurrence. In Tables 8 and 9, 
problems are associated with their designated symptoms. Many problems 
and symptoms are in one to one correspondence with one another and need 
no additional information from the problem profile. But for other 
problems, especially pain, additional factors directly influence the 
designation of the symptom. In these instances, the problems are 
mapped to the symptoms via determination of the factor combinations in 
the patients. It should be noted that there are many other factors 
b(5,i) 
Table 8. 	Designation of Symptoms from Problems and Problem Profiles. 
Problems Symptoms Factors of Problem Severity 
Variations Location* 	Activity* 
1. Breathing difficulty; 1. Exertional dyspnea 0 	 1-7 Yes 
Shortness of breath 
2. Paroxysmal nocturnal 
dyspnea 
0 8 No 
2. Cough 3. Cough 0 0 Yes 
3. Blood in sputum 4. Hemoptsis 0 0 Yes 
4. Purple skin color 5. Cyanosis 0 0 Yes 
5. Redface and lips 6. Malar flush 0 0 No 
6. Yellow skin color 7. Jaundice 0 0 No 
7. Weakness; Lack of energy 8. Weakness 0 0 Yes 
8. Fatigue; Tiredness 9. Fatigue 0 0 Yes 
9. Dizziness; Lightheadedness; 10. Syncope 0 0 Yes 
Confusion; Greying out; 
Unconsciousness 
10. Irregular heartbeat 11. Palpitations 0 0 Yes 
11. Pain 12. Typical Anginal Pain 10 1-7 Yes 
11 
13. Epigastric Anginal Pain 7 1-5 No 
15 
14. Pain from Enlarged Liver 8 0 No 
9 
15. Headaches 13 0 Yes 
14 
*Note that the factors are represented by their numbers from Table 7. 
Table 9. Designation of Symptoms from Problems and Problem Profiles. 
Problems Symptoms Factors of Problem Severity 
Variations Location* 	Activity* 
12. Swelling 16. Peripheral edema 4,5,2 0 Yes 
17. Ascites 7 0 No 
13. Weight gain 18. Weight gain from edema 0 0 Yes 
14. Appetite loss 19. Anorexia 0 0 No 
15. Nausea and 'Vomiting 20. Nausea and Vomiting 0 0 No 
*Note that the factors are represented by their numbers from Table 7. 
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associated with each of these problems, but only those listed aid in 
discriminating between symptoms. 
Once the symptom has been designated, the severity of the symptom 
must be determined. Granted, if a symptom k has not been designated, 
then its level of severity, a(k), equals zero. If the symptom is 
dichotomous and its severity representation binary, then a designated 
symptom k would have a level of severity a(k) equal to one. Such 
dichotomous symptoms for this example are revealed in the last column 
of Tables 8 and 9, where severity variations are assumed not to exist. 
Determination of the levels of severity for the remaining non-dichotomous 
symptoms is more complex, but is aided through the use of fuzzy set 
theory. 
Various fuzzy sets have been evaluated to aid in determining 
the severities of nonbinary symptoms in this example. The membership 
functions for each of these fuzzy sets directly or indirectly determine 
one or more symptoms' severity. Tables 10 and 11 illustrate these fuzzy 
sets and their membership functions. For each fuzzy set, a finite set 
ofrepresentativeelemonts,x i ,x.EX, have been selected for illustra-
tion. The membership functions have been quantified using a distance 
criterion similar to that developed by Kochen [58,59] to quantify fuzzy 
adjectives. To illustrate this technique, consider the first fuzzy set, 
Bl, denoting the strenuousness of an activity. At one end of a line, 
a stationary point denoting recumbency (no activity) is designated. 
A mark is then placed at the point on the line where the distance between 
points quantifies the strenuousness of the activity x i with respect to 
recumbency. When compared with other activities, the distance between 
Table 10. 	Fuzzy Sets Used to Determine Severities of Symptoms. 
Nonfuzzy Set-X Fuzzy Set-B 
Symbol of 
Fuzzy Set 





Lifting heavy weight 
Walking 









Pain Painfulness B2 Mild Pain .17 
Pain .5 
Severe Pain 1.0 
No Pain 0.0 
Blood Bloodiness B3 A little blood .23 
Flects of blood .39 
Slight bleeding .23 
Large amounts of blood 1.0 
Profuse bleeding 1.0 
Blood .54 
No Blood 0.0 
0 
Table 11. Fuzzy Sets Used to Determine Severities of Symptoms. 
Symbol of Nonfuzzy Set-X 	 Fuzzy Set-B 	 x. 	 uB(xi ) Fuzzy Set 




A little weight 
A lot of weight 








Colors Purpleness B5 Ashen .09 
Blue tinge .32 
Purple tinge .51 
Purple .77 
Very blue grey .21 
Very purple 1.0 
No Purple 0.0 
States of Patient Awareness of Patient B6 Unconsciousness 0.0 
Confusion .61 
Greying out .41 
Dizziness .78 
Lightheadedness .82 
Normal awareness 1.0 
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recumbency and x i represents the relative strenuousness of the activity. 
Since a distance criterion is used in the similarity matrix for the 
diagnosis decision, consistency is maintained by using a distance measure 
for membership functions of a fuzzy set. 
Once these fuzzy sets have been evaluated, their membership 
functions should be used to determine symptom severity. The severity 
of many symptoms caused by rheumatic valvular diseases increases in 
accordance with the membership function. Such fuzzy sets include 
bloodiness of the sputum, purpleness of the skin, pain of the headache 
and others. The severity of other symptoms decreases with the increasing 
membership function. Examples of these fuzzy sets include strenuousness 
of the activity and awareness of the patient. Many symptoms under con-
sideration have severities which reflect the minimum amount of activity 
which induces the symptom. By taking the complement of the fuzzy set 
of strenuous activities, the proper severity function results. The 
severity levels of syncope are also determined via this complement 
technique with regard to the patient's awareness. Table 12 better 
illustrates the use of these fuzzy sets and the functions to denote 
symptom levels, a(k). 
As can be seen from this table, most of the symptom severities 
are influenced by fuzzy sets. Many depend only upon the fuzzy sets 
while others are simple functions of fuzzy sets and location factors. 
The severity levels of coughs and peripheral edema have been effec-
tively determined without the use of fuzzy set theory. In these cases, 
nonfuzzy factors are sufficient enough to quantify the severity levels. 












Table 12. Severity Determination of Symptoms. 
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Severity 
Level-a(i) 
1. Exertional Dyspnea 0 0 1-7 0 X a(1) = 1- uBi(xi ) 
3. Cough 0 2 1-4 0 a(3) = .14 
o 2 7 0_ a(3) = .62 
o 2 1-4 1 a(3) = •79 
o 2 7 1 a(3) = . 89 
o 1 0 1 a(3) = 1.0 
4. Hemoptsis 0 0 0 3 X a(4) = uB3 (xi ) 
5. Cyanosis 1,2,3 0 0 6 X a(5) = uB5 (xi )/2 
5,6,12 
7,10 0 0 6 X a(5) 	= (uB5 (xi )/2) 	.5 
8. Weakness 0 0 1-6 0 X a(8) = 1- uBl(x i ) 
9. Fatigue 0 0 1-5 0 X a(9) = 1- uBl(xi ) 
10. Syncope 0 0 0 7 X a(l0) = 1 	
uB6(xi) 
11. Palpitations 0 0 1-7 0 X a(11) = 1- uBl(xi ) 
12. Typical Anginal Pain 10 0 1-7 0 X a(12) = (1 - uBl(xi ))/2 














15. Headaches 	 0 	0 













X 	a(15) = uB2 (xi ) 
a(16) = .24 
a(16) = .41 
a(16) = .79 
a(16) = 1.0 
= uB4(xi ) 
Table 12. Severity Determination of Symptoms. 
(Continuation) 
Symptom i* Factors Influencing Severity** Severity 
Level-a(i) 




,--1 	•,--1 	ci-i 
•,-I fl.) 	C.) 








*Note that these numbers correspond to numbers from Tables 8 and 9. 
**Note that these factors are given as numbers, corresponding to those in Table 7. 
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those pertinent to severity determination are given. 
Once the severity level, a(k), for each symptom k has been 
measured, the patient's symptom matrix, A, must be compared to the 
symptom matrix A(j), for disease stage j. In Tables 13 through 16, 
the lower bound, alb(j,k) and upper bound aub(j,k) of each symptom 
k for each disease stage j are given, where the diseases stages are 
numbered consecutively. The severity bounds for nonbinary symptoms 
are based on the same measures used to determine the patient's symptom 
severities. Weights of importance or pertinence, w(j,k), for each 
symptom k of disease stage j are given in Table 17. Although these 
weights were subjectively determined, they greatly aid in stressing 
the importance of the symptom's presence or absence from the patient. 
The positive weights of this table denote the importance of the symptoms 
being present for the given disease candidate. Conversely, the negative 
weights denote the importance of the symptom not being present for the 
disease candidate. Using these severity bounds and weights, the 
similarities between the patient's symptoms and the symptoms of disease 
stage j are determined by D2(A(j),A), j = 1,2,...,15. Thus, from 
equation (51), 
D2 (A(j),A) = [ 	fw(j,k) (alb(j,k) - a(k))I 2 
	
(62) 
k E C. 
\L: 	 lw(j,k) (alb(j,k) - a(k))I 2 
k E F. 
2 /2 
+ 	lw(j,k) (aub(j,k) - a(k))I 
k E G. 
Table 13. Symptom Matrices for the Stages 
of Valvular Heart Disease. 
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Disease alb aub 
Stage-j 0,1) 0,1) 
1 	0.0 	0.2 
2 	0.0 	0.7 
3 	o.6 	1.0 




0 1 2) 
alb 
0,3) 
0.0 0.0 0.0 
1.0 1.0 0.0 
1.0 1.0 o.o 
o.o o.o o.o 
aub alb aub alb aub 
0,3) 0,41 0,4) 0,5) 0,5) 
0.0 	0.0 	0.0 	0.0 	0.0 
0.0 	0.0 	0.0 	0.0 	0.0 
o.o 	o.o 	o.o 	o.o 	o.o 
o.o 	o.o 	o.o 	o.o 	o.o 
0.0 0.2 0.0 0.0 0.7 0.9 0.0 0.3 0.0 0.3 
0.0 1.0 0.0 0.0 0.9 1.o 0.3 1.0 0.2 0.4 
0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.6 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 
o.6 1.o 1.0 1.0 0.9 1.0 0.0 0.3 0.0 0.0 
0.0 0.7 1.0 1.0 0.0 0.9 0.0 0.3 0.0 0.3 
0.5 1.0 1.o 1.0 0.7 0.9 0.3 1.0 0.0 o.6 
0.7 1.0 1.0 1.Q 0.9 1.0 0.3 1.0 0.5 1.0 
0.0 0.7 0.0 0.0 .0.7 0.9 0.0 0.0 0.0 0.3 
0.5 0.7 0.0 0.0 0.7 0.9 0.3 0.6 0.2 0.6 












Table l4. Symptom Matrices for the Stages 
of Valvular Heart Disease. 
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Disease alb aub alb 
Stage-j (0, 6 ) 0,6) 0,7) 
1 0.0 0.0 0.0 
2 0.0 0.0 0.0 
3 0.0 0.0 0.0 
4 0.0 0.0 0.0 
5 0.0 0.0 0.0 
6 0.0 0.0 0.0 
7 0.0 0.0 0.0 
8 0.0 0.0 0.0 
9 0.0 0.0 0.0 
10 1.0 1.0 0.0 
11 1.0 1.0 1.0 
12 1.0 1.0 1.0 
13 0.0 0.0 1.0 
14 0.0 0.0 1.0 
























0.0 0.0 0.0 
0.0 0.1 0.0 
0.0 0.1 0.5 
0.0 0.1 0.0 
0.5 0.9 o.6 
o.8 1.0 o.8 
0.0 0.1 0.0 
0.3 0.7 0.5 
0.7 1.0 0.8 
0.0 0.1 0.0 
0.0 0.1 0.0 
0.1 1.0 0.5 
o.6 0.9 o.6 
o.6 0.9 o.8 




































Disease alb aub 
Stage-j (x,11) 0,11) 
1 0.0 0.0 
2 0.0 0.7 
3 0.6 1.o 
4 o.o o.o 
5 0.0 0.0 
6 0.0 0.7 
7 0.0 0.1 
8 0.1 0.7 
9 0.7 1.0 
10 0.0 0.7 
11 o.6 1.0 
12 0.6 1.0 
13 0.0 0.0 
14 0.0 0.0 
15 0.0 0.0 
alb 	aub 
















alb aub alb aub alb aub 
(x,13) (x,13) (x,14) (x,14) (x,15) (x,15) 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.2 
1.0 1.0 1.0 1.0 0.4 1.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 o.o 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 0.0 0.0 0.0 0.0 
0.0 0.0 1.0 1.o o.o o.o 
0.0 0.0 1.0 1.0 0.0 0.2 
0.0 0.0 1.0 1.0 0.2 0.6 
0.0 0.0 1.0 1.0 0.6 1.0 
Symptom Matrices for the Stages 
of Valvular Heart Disease. 
Table 16. 	Symptom Matrices for the Stages 
of Valvular Heart Disease. 
Disease alb aub alb aub alb aub alb aub alb aub 
Stage-j (j,16) (j,16) (j,17) (j,17) (j,18) (j,18) (j,19) (j,19) (j,20) (j,20) 
1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
5 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 
6 0.3 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 
7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
10 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
11 0.0 0.5 0.0 0.0 0.0 0.0 1.0 1.0 0.0 0.0 
12 0.4 0.8 1.0 1.0 0.3 o.6 1.0 1.0 1.0 1.0 
13 0.0 0.5 1.0 1.0 0.0 0.3 1.0 1.0 0.0 0.0 
14 0.4 0.8 1.0 1.0 0.3 o.8 1.0 1.0 1.0 1.0 
15 0.7 1.0 1.0 1.0 0.5 1.0 1.0 1.0 1.0 1.0 
Table 17, Pertinent Weights of Each Symptom to the Diagnosis of the Disease Stages. 
Symptom 
1 2 3 4 5 
Disease Stage-j 
6 	7 	8 9 10 11 12 13 14 15 
1 .4 .8 1.0 -.1 .6 1.0 .6 .8 1.0 .8 1.0 1.0 .6 .6 .6 
2 -.1 .4 .8 -.1 -.1 -.1 -.1 -.1 .7 .3 .6 .9 -.1 -.1 -.1 
3 -.8 -.6 -.4 -.1 .6 .8 -.4 .4 .6 .8 .8 1.0 .3 .6 .8 
4 -.8 -.6 -.3 -.6 .2 .8 -.6 -.4 .2 .5 .8 1.0 .1 .7 1.0 
5 -.8 -.4 -.1 -.1 .5 .7 -.8 -.4 -.1 .4 .7 .9 .6 .7 .9 
6 -.8 -.6 -.4 -.8 -.4 -.1 -.5 -.3 -.1 .3 .5 .7 -.1 -.1 -.1 
7 -.8 -.8 -.2 -.8 -.8 -.2 -.6 -.6 -.2 .3 .5 .7 .5 .7 .9 
8 -.1 .3 .8 .5 .8 1.0 .3 .5 .7 .4 .7 .9 .5 .8 .8 
9 .3 .5 .8 .5 .8 1.0 .3 .5 .7 .4 .7 .9 .5 .8 .8 
10 .5 .6 .9 .5 .7 .9 -.6 -.6 -.4 -.6 -.6 -.4 -.1 -.1 -.1 
11 -.4 .5 .7 -.6 -.4 .6 .3 .5 .8 .5 .7 1.0 -.1 -.1 -.1 
12 -.4 -.1 .6 .4 .6 .9 -.8 -.8 -.6 -.5 -.3 -.1 -.1 -.1 -.1 
13 -.1 -.1 .7 -.1 -.1 -.1 -.8 -.8 -.6 -.5 -.3 -.1 -.1 -.1 -.1 
14 -.8 -.6 -.4 -.8 -.6 -.2 -.8 -.6 -.2 -.4 -.1 .6 .6 .8 1.0 
15 -.2 .4 .8 -.4 -.4 -.2 -.4 -.4 -.4 -.4 -.4 -.1 .4 .6 .8 
16 -.8 -.4 -.1 -.1 .4 .8 -.6 -.3 -.1 -.1 .4 .8 .6 .8 1.0 
17 -.8 -.4 -.2 -.8 -.4 -.2 -.8 -.4 -.2 -.6 -.1 .6 .6 .8 1.0 
18 -.6 -.4 -.1 -.1 .4 .8 -.6 -.3 -.1 -.1 -.4 .6 .6 .8 1.0 
19 -.6 -.3 -.1 -.3 -.2 -.1 -.6 -.3 -.1 .3 .4 .7 .4 .6 .8 
20 -.8 -.6 -.3 -.7 -.3 -.3 -.7 -.5 -.3 -.1 .4 .7 .4 .6 .8 
j = 1,2,...,15 
where 
C. = fklalb(j,k) = aub(j,k) E [0,11 , 
a(k) E {0,1}, 1 s k s 20} 
F. = fkla(k) < alb(j,k), 1 s k s 20} 
G. = [kla(k) > aub(j,k), 1 s k s 201 
w(j,k) E [0,1] 
aub(j,k), alb(j,k), a(k) E [0,1] 
By combining the similarity measures of patient history and 
symptoms,thesimilaritymeasure . Yjn
.,needed to reach a medical 
hypothesis, can be determined. Consequently, 
yjn 
	
f (H(i),H) + D2 (A(j),A)1 	 (63) 
i = 1,2,...,5 
j = 1,2 ,.. .,15 
The solution to the following problem yields the most likely disease 
stage candidate for the medical hypothesis. 
Min. Yjn 
(01) 
j = 1,2,...,15 
Other strategies, like that represented in equation (57), yield a group 
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of the most possible disease stages, rather than a single disease stage. 
This chapter has presented an illustrative example of the 
diagnosis decision process and its modelling representations. To 
determine the usefulness of this developed model, diagnoses using 
information derived from this example are analyzed in Chapter V. 
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CHAP1ER V 
COMPUTERIZATION AND VATJDATION 
OF THE FUZZY DIAGNOSIS MODEL 
By incorporating the information of the illustrative example 
into the diagnosis decision model, hypothesis decisions involving 
valvular heart diseases can be reached. This chapter attempts to 
validate the diagnosis model by analyzing such diagnosis decisions. 
The purpose of this validation is to obtain some insight into the 
model's performance and to identify any problem areas or deficiencies 
of the model. To make such a validation feasible, computerization of 
the fuzzy diagnosis model is considered necessary. Consequently, a 
computer program for the diagnosis of valvular heart diseases via fuzzy 
set theory is offered herein. By contrasting the diagnosis of the 
computerized model with the diagnoses of a physician, the validity or 
preciseness of the proposed model can be studied. 
Computerization of the Model 
The computer program developed for this phase of the study centers 
upon the mathematical modelling and medical data presented in Chapter IV. 
The flowchart used to formulate this program is illustrated in Figure 2. 
A complete listing of the Fortran programming used to reach hypothesis 
decisions may be found in Appendix C. 
The computerized program is itself interactive in nature, taking 
on some of the sequential aspects of the actual decision process. 
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Pertinent questions concerning past medical and nonmedical history, as 
well as symptom aspects are asked. Patient problems, problem factors, 
and fuzzy severity aspects are put forth singularly, so that full 
information concerning each specific problem may be discerned. In 
this way, all important information for symptom and symptom severity 
determination is obtained. Answers to each of these questions must be 
derived from answer categories supplied by the computer output or from 
specific answer sheets supplied with the program in Appendix C. Member-
ship functions of fuzzy sets, problem location factors, continuity 
determinators, problem inducing factors, and problem severity specifics 
must be read from these sources or listings and used as input data at 
the particular point of the interaction. 
The various output of this program directly aids the physician 
in reaching a hypothesis. Such program output includes: 
1. Measured patient history matrix, H. 
2. Measured patient symptom matrix, A. 
3. Ordered table of patient - disease stage similarity measures, 
D(X ( j),Xn ) 
where 
D(X(j),Xn ) = D(H(i),H) 	D(A(j),A) 	 (65) 
i = 1,2,...,5 
j = 1,2,...,15. 
Quantified patient matrices should give the physician a better idea of 
the information present in the decision, since the matrices are in 
such a concise form. By having a table of ordered disease candidates, 
1o6 
the physician should be better able to determine his future strategy and 
possible alternate disease candidates. Singular hypothesis candidates 
or multiple candidates may result from close evaluation of this table. 
A summary of this computerized model's input and output is given in 
Figure 3. 
Model Validation 
As was previously mentioned, the fuzzy diagnosis model is 
validated by comparing computerized hypotheses and physician-made 
hypotheses when the same information is used for both decisions. 
Initially, patient medical files were sought as the source for physician 
made decisions. History and symptoms could have been extracted from 
these files and used as input for the computerized decision. Unfortu-
nately, due to an increased prote'ction and confidentiality of patient 
information in the local hospitals, such patient files were unobtainable. 
Aside from this fact, valvular heart disease does not occur prolifically, 
thus making it difficult to obtain vast quantities of information. 
Therefore, some other appropriate and effective technique had to be 
devised to validate this model. 
Consequently, this fuzzy diagnosis decision model has been 
validated via comparisons with mock physician diagnosis decisions. 
This process involves selecting a group of history aspects and problems 
relevant to valvular heart disease. Associated with each problem are 
problem factors and specifics used to determine a problem's severity. 
All the aspects in this patient attribute group are unquantified and 
should be left in patient description form, as if they had been related 
INPUT OF PROGRAM 
I. Physician Input 
A. Past history relevant to disease possibilities 
1. Binary history matrix for each disease 
2. Weights of history aspects for each disease 
B. Present symptoms of possible disease stages 
1. Symptom severity bounds for each disease 
stage 
2. Weights of symptoms for each disease stage 
II. Patient Input 
A. Aspects of past patient history 
B. Patient problem areas 
1. Specific problems 






OUTPUT OF PROGRAM 
I. Input Data 
II. Measured History Matrix of the Patient 
III. Measured Symptom Matrix of the Patient 
IV. Similarity Measures of Patient Sickness 
and Possible Disease Stages 
Figure 3. Diagram of Input and Output Information 
for the Computerized Diagnosis Model. 
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by the patient. For each patient's group of attributes or set of 
patient history and problems, the physician selects one or more possible 
disease stage candidates for the medical hypothesis. It should be noted 
that the physician's definition of symptoms must be consistent with those 
used for the computerized model. 
A comparison between mock physician hypotheses and the results 
of the computerized decision model involving the previous medical example 
is presented in Table 18. One column of this table corresponds to the 
mock physician hypotheses, while another column corresponds to the 
hypotheses reached by the fuzzy decision model. The model and physician 
concurred on four of the hypothesis decisions, with the physician's 
hypothesis consistently being one of the six most likely disease stage 
candidates. This is illustrated in Table 18 in the column corresponding 
to the ranking of the physician's hypothesis. The last column of Table 
18 corresponds to the rank of the physician hypothesis regardless of 
disease stage development. This would be similar to results of past 
modelling techniques where a disease's development is assumed constant. 
Certainly the results in Table 18 illustrate discrepancies and 
problems with the proposed model. These discrepancies are probably 
due to a variety of factors. First of all, the diseases and disease 
stages are very similar to one another and lack numerous or severe 
discriminating factors. Furthermore, measurement or weighting inac-
curacies are evident when the validation data is analyzed. Symptoms 
relevant to aortic and mitral valve diseases, such as angina, dyspnea, 
and syncope, are not specifically pertinent to tricuspid valve disease. 
Unfortunately, such symptoms are not negatively weighted enough for 
Patient 
Number 
1 	Severe Mitral Stenosis Severe Mitral 
Physician 
Hypothesis-K 
Computer Aided Similarity Highest Rank 
Hypothesis 	Rank of K for Any  
1 	1 








Insufficiency 	 Aortic 
Insufficiency 







4 	Severe Tricuspid 
	
Severe Aortic 	4/10 
	
3/7 
Insufficiency and Stenosis 
Intermediate Mitral 
Insufficiency 
5 	Severe Mitral Stenosis Severe Tricuspid 4/1 
	
4/1 
and/or Severe Tricuspid Insufficiency 
Insufficiency 
6 	Intermediate Mitral 
Insufficiency 
7 	Severe Mitral Stenosis 
8 	Severe Tricuspid 
Insufficiency 
Mild Tricuspid 	6 
Insufficiency 




























tricuspid insufficiency and the resultant distance measure or similarity 
measure is somewhat erroneous. Symptoms differentiating aortic stenosis 
from aortic insufficiency must also receive measurement adjustments. 
Weights associated with aortic stenosis symptoms, such as angina and 
syncope, must be negatively increased for the stages of aortic insuffi-
ciency. Slight measurement revisions must also be made for the stages 
of tricuspid insufficiency and aortic insufficiency since the computerized 
hypothesis named the correct disease but the incorrect disease stage. 
Correction of these measurement discrepancies should result in a more 
realistic and accurate diagnosis model. 
Since the initial problems confronted by this fuzzy modelling 
approach have been designated, additional modelling development should 
follow. Granted, as a diagnostic tool, the initial accuracy of this 
fuzzy diagnosis model is not extremely high, but the results are 
encouraging enough to warrant future model development along these 
lines. It must be pointed out that the decision model presented in this 
work did succeed in representing more of the influential aspects important 
to actual diagnosis decisions, than previous mathematical non-fuzzy 
models. Future research in model and data development via fuzzy systems 
theory should result in ever improving accuracy and preciseness. 
CHAPTER VI 
SUMMARY AND FUTURE RESEARCH 
Research for this work comprises the initial phase of fuzzy 
model development in the area of medical decision making. Although 
fuzzy systems theory is discussed in prominent journals and references, 
applications to real life situations have been somewhat sparse and 
infrequent. This research has been presented in an attempt to allevi-
ate this deficiency. 
Medical decision making, strongly influenced by a variety of 
imprecise and difficult to quantify aspects, has presented itself as a 
fertile area for applications of.fuzzy set theory. As illustrated in 
Chapter II, these aspects exist throughout the various decision processes 
of the physician. Whether in the diagnosis decision process, the test 
selection process, the treatment selection process, or the treatment 
of the patient, fuzziness underlies many of the decisions important to 
the well being of the patient. In the diagnosis decisions, fuzziness 
is found in the physician-patient interaction and in information con-
cerning the state of the patient. This includes imprecise patient 
communication of symptoms, as well as abnormality or severity measure- 
ment of patient attributes. In the test selection process, many factors 
influencing the choosing of a test have been designated as vague or 
difficult to quantify. These involve the usefulness, costliness, need, 
convenience, and danger of the test. Selection of the proper 
ill 
treatment is also constrained by such fuzzy variables, but their 
respective importance to the decision varies. Fuzziness also occurs 
in the actual treatment or treatment management of the patient, through 
instructions that can be vague, imprecise, or unquantified. 
Accompanying the descriptions of these decision processes and 
their intrinsic fuzziness has been an evaluation of their past mathe-
matical representations. Oversimplification and misrepresentation of 
fuzzy and nonfuzzy aspects has been a fault of past models. In an 
effort to correct past deficiences, fuzzy set theory and other con-
ventional techniques have been suggested for more appropriate modelling. 
The specific model developed in this research centers on the 
diagnosis decision process, which includes decisions upon medical 
hypothesis, preliminary diagnoses, and final diagnoses. Representa-
tions of patient information have been developed and quantification 
techniques for this information, including those of fuzzy set theory, 
have been offered. Organization and incorporation of patient data, 
both fuzzy and nonfuzzy, have been a major consideration of this 
modelling phase. Information including patient history, symptoms, 
signs, and test results can be input for the developed diagnosis 
decision model. The diagnosis decision model suggested involves the 
use of cluster analysis techniques to determine the most likely disease 
candidate for the diagnosEs. Similarities between the patient's sick-
ness and all possible disease stages should be calculated via this 
model to determine the most similar disease stage. 
A medical example has been given in Chapter IV to illustrate an 
application of the developed diagnosis model. The information in the 
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example involves past history and symptoms of the patient and disease 
stages. Through the specifics of the example, a medical hypothesis 
of the patient in the disease area of valvular heart disease can be 
reached. Specific information concerning patient history, patient 
problems, problem factors, and fuzzy severity description have been 
given. Fuzzy sets have been created, their membership functions 
defined, and their role in symptom severity determination specified. 
Using the data from the medical example, Chapter V and Appendix C 
have presented a computerized program of the diagnosis decision model. 
With this computerized version, validation of the fuzzy diagnosis model 
becomes feasible. As has been pointed out, patient files were not 
available for this model validation. Thus, an alternate technique, 
involving mock diagnoses by a physician, has been devised to determine 
the appropriateness of the proposed model. Comparisons between 
physician diagnoses and computer diagnoses with the same information 
have been made to determine this appropriateness. The results of this 
validation have shown initial promise for the developed model as well 
as the need for further model analysis. 
Since this is an initial phase of fuzzy model development in 
the physician-patient decision area, future research offers many 
possibilities. These can be classified into three categories. 
1. Designation and discussion of additional fuzzy aspects and 
considerations in the medical decision making field. 
2. Standardization of medical definitions and influential 
factors relevant to physician decisions. 
3. Tmprovements upon measurements of the existing model and 
additional model development. 
Each of these is in itself a formidable research task. 
Although this research identified many of the major fuzzy aspects 
within the physician-patient interaction and relationship, further 
designation and interpretation of fuzzy considerations should be made. 
Refinements concerning the fuzzy aspects already designated, or addi-
tional factors of fuzziness warrant future study. In this research, 
factors influencing fuzziness within the patient-physician relations 
were outlined and discussed. Future work might center on influences 
outside this interactive relationship. Such research would include 
cultural influences upon fuzzy concepts, fuzzy interpretations, and 
assessment of fuzziness. 
Possibly the most imposing research task involves attempts to 
standardize medical definitions and other medical factors. For future 
mathematical study in this field, more consistent definitions and 
interpretations of medical evidence must be developed. In this 
research, the possible symptoms for a given disease are fairly uniform 
from physician to physician and from reference to reference. However, 
the determination of severity levels of symptoms is based on less 
consistent information. Variations between physicians exist in the 
area of symptom definitions and determination of factors influencing 
symptom severity. One physician may have one criterion to determine 
the severity of a symptom, while another may use a completely different 
approach. This is the reason for assuming symptom definitions and 
severity factors listed in Appendix B. Uniform criteria must be 
developed in the future for determining symptom severity and other 
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diagnostic medical considerations. Such efforts are presently being 
undertaken by the American College of Physicians, but this will only 
be a first step in achieving the desired medical standardization. 
The final category for possible future research involves 
refinement and further development of the fuzzy diagnosis model 
presented in this research. Refinements should be made on the 
proposed model to obtain more precise symptom and weight measurements. 
A broader base of opinion needs to be constructed for determination of 
these values. The Delphi Method for polling professional opinion might 
be a feasible approach to solve the problem. Once such expert opinion 
is obtained, further measurement refinement should be made. By 
validating the diagnosis model with more patient diagnoses, further 
information involving improper measurements should result. Sensitivity 
and statistical analysis might then be performed to evaluate this 
information. Since the example presented stops with the medical 
hypothesis, illustrating the decision process to the final diagnosis 
is desirable to verify other modelling suggestions involving sign 
designation and test result interpretation. Alternate physician 
decision processes, such as test and treatment selection, also need to 
be modelled via fuzzy set theory so that overall comprehensive 
diagnostic and treatment models might be feasible. 
To accomplish this research, collaboration between the mathe-
matical and medical fields was essential. Additional research, whether 
for educational or practical use, will demand even closer cooperation 
between individuals in their respective fields. Hopefully, this and 
other future mathematical models will be applied and used in the medical 
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profession. Initially, such computerized models may serve only as 
training tools for medical students and interns. As model accuracy 
and acceptance among physicians increase, medical decision models 
might eventually replace decision making aspects of physicians. 
APPENDIX A 
ETEMENTS OF FUZZY SET THEORY 
Fuzzy Sets  
As was stated earlier, a fuzzy set is defined as a set of elements 
in which there is no distinct boundary between the elements that belong 
to the set and those which do not belong. Hence, an element in a fuzzy 
set has a degree of membership rather than full membership or nonmember-
ship. 
ConsiderasetX=fx.1where x. is a generic element of the 
set X. A fuzzy set A in X is .a set of ordered pairs defined as 
A = {(xi , uA (x i ))ixi E X} . 	 (66) 
Thefunctionul (xi )iscalledthemembershipfunctionofx.in A which 
maps X to the membership space M, where M = [0,1]. This is written 
symbolically as 4A : X -+ M. If A is a nonfuzzy set, then uA (xi ) = 0 
or 1, according as xi A or xi E A. 
Example: Consider the clinical test involving white blood cell 
(leukocyte) count in a given patient. Let 
X = fxi lxi > ol . 	 (67) 
Let A be a fuzzy set of highly abnormal white blood cell count 
(indication of infection). Define the membership function uA, which 
maps X into [0,1] as follows: 
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0 , for x. < 11,000 
1 
uA(xi ) = 	(xi - 11,000/9,000 for 11,000 s x i s 20,000 	(68) 
1,f01.. .x.1 
 > 20,000 
As can be seen from this membership function, the abnormal range for 
leukocyte counts begins at 11,000. 
Definitions Involving Fuzzy Sets 
Empty Fuzzy Set  
A fuzzy set is empty if and only if 
uA ( xi )  = 0 ' V x. E X . 
	 (69) 
Equality 
Two fuzzy sets A and B are equal (A = B) if and only if 
u
A(xi) =11B(x 	




The complement of a fuzzy set A, denoted by A, is defined by 
u'
A
(x.) = 1 - uA(xi ) , 
V x. E X . 
Containment  
Let A and B denote two fuzzy sets in X. A is contained in B 
or A is a subset of B(A B) if and only if 
uA(x i ) s u_B
(x.) 	, V xi E X . 	 (72) 
Union  
Let A be a fuzzy set in X with a membership function denoted by 
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u
A1i (x.),VxEX. Let B be a fuzzy set in X with a membership function 
denotedbyuB(xi ),Vx.1 
 E X. The union of fuzzy sets A and B is a fuzzy 
set C, written as 




 (x.) = max[u
Ai 
 (x), ii  (x.)] 	, V. x. (E 
B ( 73) 
or, in abbreviated form 
uc = uA V uB . 
Intersection  
Let A and B be two fuzzy sets, denoted by the membership functions 
u.A (xi )andyx.),Vx.EX, respectively. The intersection of fuzzy 
sets A and B is a fuzzy set C, written as C = A I) B, where 
1.1C (x-)=111111-[11A 1-1B (x Th ilx.EX  "i 
or, in abbreviated form 
uc = uA A uB . 
Convexity 
A fuzzy set A is convex if and only if the sets F
a 
defined by 
F = fx.111A  (x.) 	a11 a 	1 




if and only if 
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uA[xxl 




1  and x2 in X and all X in [0,1]. 
Decision Making in a Fuzzy Environment 
When making decisions in a fuzzy environment, the objectives of 
the decision, 0, and the constraints of the decision, C, are fuzzy sets. 
The system under consideration, X, is nonfuzzy in nature, usually the 
real numbers. The objective functions and constraints are characterized 
by the membership functions u0 (xi ) and uc (xi ) respectively. The member- 
	
ship function of the decision, 	(x.) is 
up(x i ) = u0 (x i ) A u0 (xi ) 	V xi E X . 
A decision can then be based on .the membership function 
( 79) 
1 
,.) Vx. EX. 
1 
Example: The objective of this example is to find x
i such that 
it is substantially larger than 10. Thus, 




(x) = 1/(1 	(x. - 10)-2) 	
1 
for )c. 	10 . 
1  
(8o) 
The constraint of the example is that x i should be in the vicinity of 
11. This is characterized by the membership function 
1/(1 + (x i - 11) 4 ) 	V
1  E X • 
	 (81) 
The membership function, up(xi ) = u0 (xi ) A uc (xi ), V xi E X, where 
np./(1+(x
i 
 -10) -2),1/1+(x.-11) 4 1 for x
i 	
10 i 
ilD(xi) 	 (82) 
for x. < 10 
1 
APPENDIX B 
DESCRIPTION OF MEDICALLY DESIGNATED SYMPTOMS 
Symptom and Symptom Severity Definitions  
Exertional Dyspnea  
Shortness of breath upon exertion; effort provokes inability 
to catch breath; problems breathing upon exertion. 
Severity of Symptom - determined by minimum level of severity 
accompanying symptom. 
Parosysmal Nocturnal Dyspnea - Orthopnea  
Extreme shortness of breath while asleep; often awakes patient 
after few hours of retirement; rapidly relieved when patient 
sits up and breathes deeply; patient has need to get "fresh 
air"; can occur more than once a night; usually night after night. 
Severity of Symptom - single level of severity assumed. 
Cough* 
For relief of tickling in throat; may occur upon exertion, 
recumbency or incessantly. 
Severity of Symptom - severity of symptom depends upon activity 
of patient and productiveness of cough. 
Hemoptsis* 
Blood coughed up after tickling sensation in throat; blood tinged 
sputum; bloody sputum from respiratory tract. 
*Note: Pulmonary Edema is assumed to be equivalent to severe 
levels of cough, accompanied with severe levels of hemoptsis. 
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Severity of Symptom - severity depends upon bloodiness of sputum. 
Cyanosis  
Purplish or greyish blue coloration of the skin and the mucous 
membranes due to deficient oxygenation of the blood. 
Severity of Symptom - severity of the symptom depends upon the 
location of the symptom and degree of purpleness. 
Malar Flush 
Deep redness of cheeks and of lips, due to congestion of fine 
capillaries in the cheek bones. 
Severity of Symptom - single level of severity assumed. 
Jaundice  
Yellowish or yellow-greenish discoloration of the skin and other 
body tissues and fluids by bile pigments. 
Severity of Symptom - single level of severity assumed. 
Weakness  
Lack of energy, inability to move, lack of strength. 
Severity of Symptom - severity determined by limitations on 
activity. 
Fatigue 
Exhaustion from exercise, laziness, tiredness from activity. 
Severity of Symptom - severity determined by minimum activity 
causing fatigue. 
Syncope  
Symptom complex characterized by sudden transcient weakness, 
dizziness, and faintness. 
Severity of Symptom - the severity of the symptom depends upon 
123 
the unawareness of the patient. 
Palpitations  
Consciousness of rapid, forceful, irregular beating of the heart, 
increased awareness of normal heart action, pounding heart 
sensations. 
Severity of Symptom - severity of the symptom depends upon the 
minimum level of activity accompanying symptom. 
Typical Anginal Pain  
Angina pectoris is typically characterized by the occurrence of 
nonspecific substernal pain of varying discomfort. This pain 
usually radiates from the sternum upward to the neck and down 
the inner side of the lieft arm to the little or ring finger. 
The pain is usually brought on by exertion or intense mental 
emotion and lasts from a few seconds to a few minutes. 
Severity of Symptom - the severity depends upon the minimum 
activity accompanying symptom and radiation of pain to other 
locations. 
Epigastric Anginal Pain  
Severe epigastric pain, occurring upon exertion, radiating back 
to the spine or upward to the sternum. 
Severity of Symptom - single level of severity assumed. 
Pain From Enlarged Liver  
Pulsating non-radiating pain in upper abdomen, lower chest. 
Severity of Symptom - single level of severity assumed. 
Headaches  
Pain associated in head and upper neck region. 
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Severity of Symptom - the severity depends upon the painfulness. 
Peripheral Edema  
Accumulation of excess fluids in extremities of body. 
Severity of Symptom - the severity depends upon the location 
and continuity of the swelling. 
Ascites (enlarged liver)  
Slight bulging of the flanks, unnatural fullness of lower 
abdomen, accompanies right ventricular heart failure, preceded by 
swelling and edema in legs and abdomen wall. 
Severity of Symptom - single level of severity assumed. 
Weight Gain from Edema  
Increase of weight, due to edema. 
Severity of Symptom - severity of symptom dependent upon 
increase in weight. 
Anorexia  
Lack of desire to eat due to liver failure. 
Severity of Symptom - single level of severity assumed. 
Nausea and Vomiting  
Stomach sickness, regurgitation, due to liver failure. 
Severity of Symptom - single level of severity assumed. 
APPENDIX C 
COMPUTER PROGRAM 
FOR THE DIAGNOSIS MODEL 
125 
Problem - Factor Sheet: Input Data 
Patient Problem Areas 
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09. Dizziness; Lightheadedness Confusion; 
Greying out; Unconsciousness 
00. No more problems 
1. Shortness of breath 
2. Coughing 
3. Blood in sputum 
4. Purple skin color 
5. Red face and lips 
6. Yellow skin color 
7. Weakness 
8. Fatigue  
10. Irregular heartbeat 
11. Pain 
12. Swelling 
13. Weight gain 
14. Appetite loss 
15. Nausea and vomiting 
Continuity Factors 
02. Intermittent 







Location Factors  
6. Legs 
7. Abdomen 
8. Upper abdomen 
9. Lower chest 
10. Middle chest  
11. Inner left arm 
12. Arms 




00. No specific activity 
1. Running 
2. Climbing 
3. Lifting heavy weight 
4. Walking  





Symptom Severity Sheet: 
Headache - Pain 
1. Mild pain - 	 0.17 
2. Pain - 	 0.50 
3. Severe pain - 	 1.00 
Hemoptsis - Bloodiness 
Input Data 
Weight gain - Increasing weight 
1. 	5 lbs. 	- 0.28 
2. 	10 lbs. 	- 0.50 
3. 	15 lbs. 	- 0.75 
4. 20 lbs. 	- 1.00 
5. A little weight - 	0.22 
1. A little blood - 0.23 6. A lot of weight - 0.55 
2. Fleets of blood - 0.39 
3. Slight bleeding - 0.23 Cyanosis - Purpleness 
4. Large amounts of blood - 1.00 1. Ashen - 0.09 
5. Profuse bleeding - 1.00 2. Blue tinge - 0.32 
6. Blood - 0.54 3. Purple tinge - 0.51 
4. Purple - 0.77 
Cough - Productivity 5. Very blue grey - 0.21 
1. Productive - 1.00 6. Very purple - 1.00 
2. Nonproductive - 0.00 
Syncope - Awareness of patient 
1. Unconsciousness - 0.00 
2. Confusion - 0.61 
3. Greying out - 0.41 
4. Dizziness - 0.78 




C THIS PROGRAM INCORPORATEs CLUSTER ANALYSIS ANC FUZZY SET THEORY TO 













C READ IN PHYSICIAN INPUT 
C 









C READ IN UPPER SEVERITY AND LOWER SEVERITY BOUNDS FOR SYMPTOMS 
C 
REA0(2.37)((XL(I,J),I=1.15).J=1.20) 
REA0(2.37)((XU(I.J),I=1.15).J 2 1.20) 
37 	FORMAT(15F3.01 
C 





C PRINT OUT INPUT IF DESIRED 
C 
WRITE(6.90) 
90 	FORMATi3X,41H00 YOU WANT INFORMATION MATRICES PRINTED /24HENTER 1 
1(YES) OR 0 (NO).) 
REA0(5.95)INF 
45 	FORMAT(II) 
IF(INF.NE.1)G0 TO 130 
C 
C 	PRINT OUT INPUT FOR DISEASES 
C 
WRITE(6.100)((C(I.J).J=118),I=1.5) 

















135 FORMAT(45HHOW MANY PATIENT DISEASES WILL BE DIAGNOSE° /17HREA0 IN 
1 12 FORMAT) 
REA0(5.143)NUM 
140 FORMAT(I2) 
00 999 N=1.NUM 
C 
C INITIALIZE PATIENT HISTORY MATRIX 




1  8 
SIGNUM...4 
C INITIALIZE PAI1E. NT sYMPTJM MAT,ZIA 
00 160 .1.1.?0 
X(.1 ► .81GNUM 
160 CONTINUE 
C 
C INITIALIZE OTHER VARIA8LES 
00 180 1.1.15 
00 170 J.1.20 




00 1L5 r=1.10 











210 FORMAT(10X.21HPAT1ENTS PAST HISTJRY/43X.5oHREAD IN PATEINTS PAST 
IOISEASES USING APPROPRIATE NUM3ER//10X.17H1..RHEUMATIC FEVER//10X.1 
20H2 ..SYPHILIS//10X.30H3-.RHEUMATIC FEVER AND SYPHILIS//1.11X.24H4-.NONE 
3 OF THESE OISEASES/// 
C 
C 
C READ IN PAST DISEASES 
RIA0(5.215)IOS 
215 FORMAT(I1) 
IF(IOS.NE.1)G0 TO 220 
V(1L.1.0 
GO TO 240 
220 IF(IOS.NE.2)G0 TO 225 
V(2)=1.0 
GO TO 240 
225 IF(10S.NE.3)G0 TO 230 
V(1)=1.0 
V(2)=1.0 
GO TO 240 
230 V(3)=1.0 
240_ CONTINUE 
IFiV(3 ► .NE.1.0)G0 TO 245 
C 
C DETERMINE IF SYMPTOMS OF UNDIAGNOSED DISEASES HAVE EXISTED 
C 
WRITE(6,242) 	 • 
242 FORMAT(///31HHAS THE PATIENT EVER HAD EITHER//3)(.37HOF THE FOLLOWI 
1146 GROUPS OF SYMPTOMS //31(.40HIF SO DESIGNATE WITH APPROPRIATE NU 
2WIERS//10X,28111 ■ 81GH FEVER ANO SORE JOINTS//10X,26H2..PINK SKIN RAS 
3H AND SOR6S//10X.18H3...NEITHER OF THESE/// 
REA0(5.243)ISTM 
243 FORMAT(I1) 
IF(ISTM.NE.I)G0 TO 244 
V(1).1.0 
V(3)=0.0 
GO TO 246 






C READ IN PATIENTS SEX 
C 
WRITE(6,250) 




IF(ISEX.NE.1)G0 TO 260 
V(4)•=1.0 





C READ IN PATIENTS AGE GROUP 
C 
WRITEto.2b9 ►  
269 FORMAT(///53HREA0 IN PATIENT',GE CATEGORY USING APPROPRIATE NUMBER 
11/10X912H1-tUNOER 301 //1 0 K.1H2 - 130 - 601//111X.11H3-(OVER 6011 
REA0t5.1751IGE 
275 FCAMATt111 
IFTIGE.NE.1/GO TO 280 
Vt6i=1.0 
GO TO 300 
280 IFtIGE.NL.2/60 TO 290 
Vt71=1.0 




C 	PATIENTS HISTORY MATRIX IS NOW KNOWN 
C 
C DETERMINE SIMILARITY BETWEEN PATIENTS HISTORY ANC DISEASE I 
C 
00 330 1=1,5 
OVTI/z0.0 
DO 3211 J=1,8 
XV(I.J)=tC(I.J)*(V(J)..VV(I.J11)"2 
















505 FOkMAT(52MREAC IN A PATIENT PROBLEM AREA USING THE APPROPRIATE/2X. 
138HNUMBER FROM THE PROBLEM FACTOR SHEET /13HUSE 12 FORMAT/) 
READt5.5101IPtMM/ 
510 FORMAT(I2) 




C READ IN LOCATIONS OF PROBLEM 
C 
WRITEt6.515/ 
515 FORMATUX.44HHOW MANY LOCATIONS GOES THIS PROBLEM HAVE// 
READt5.520)NLOC 
520 FORMATtIl/ 
IFtNLOC.E0.0/G0 TO 530 
WRITE(6.522) 
522 FORMATt3X,25HREA0 IN PROBLEM LOCATIONS/3X.31HOESIGNATE ONE LOCATIO 
IN PER LINE/3X,13HUSE I2 FORMAT// 
MLOC=NLOC+5 
READ (5,523 )tIB(I,K),I=6,MLOC/ 
523 FORMAT(I2) 
C 
C DETERMINE IF PROBLEM IS CONTINUOUS OR INTERMITTENT 
530 CONTINUE 
WRITE(6/532) 
532 FORMAT(3X.29HREAO IN CONTINUITY OF PROBLEM/3X,39HUSING NUMBER FROK 
1 PROBLEM- FACTOR SHEET/3X,13HU5E 12 FORMAT) 
REA0(5.535)IBUS,K ►  
535 FORMAT(I2) 
C DETERMINE ACTIVITY ACCOMPANYING INTERMITTENT PROBLEM OCCURRENCE 
lit/Elt3•K1.E0.11G0 TU 550 
WRITE(6.537) 
537 FORMAT(3X.51HREAD IN MINIMUM ACTIVITY OR ACTIVITIES ACCOMPANYING/3 
1X,18HSYHPTOM OCCUKH, NICE//3X,33HU..1E APPROPRIATE NUMBER FROM SHEcT/3 
2X147HENTER TWO ACTIVITY NUMLIERS.OHE NUMBER PER LINE//3X.14HUSE 12 
3 FORMAT) 




READ IN StVr_KITY SPECIFIC 44LUE5 FOR CERTAIN PRJOLEMS 
WRITE (t.5521 
552 FORMATtix.47HENTER sLVRITY VALUE FUR EACH REQUESTED SYMPTUM/3x.26 
IHUE SYM,, F3M ickic:RITY SHEET/JX.itHUsL 4(4.2) FORMAT// ►  
IF(K.NE.Z)GJ TO 55, 







IF(K.N.3)G0 TO 560 





GO to 545 
560 CONTINUE 
C FIND SEVERITY OF CYANOSIS 





GO TO 595 
570 CONTINUE 
C 	FIND SEVERITY OF SYNCOPE 





GO TO 595 
575 CONTINUE 
C 	FIND SEVERITY OF HEADACHE 
IF(K.NE.11)GO TO 585 
00 578 I=6.10 
•ED•13.JR.I8(I. K1 •ED•1•)6%) TO 580 
578 CONTINUE 
GO TO 585 
580 CONTINUE 




583 FORMAT(F4.2) • 
GO TO 595 
585 CONTINUE 
C FIND SEVERITY OF WEIGHT GAIN 
590 IF(K.NE.13)G0 TO 591 
wRITE(6,592) 
592 FORmAt(3x.11HwEIGHt GAIN) 
READ(5.594)8(2,13) 
594 FORMAT(F4.2) 
GO TO 595 
591 WRITE(0,597) 
597 FORMAT(//3x.24HNo SEVERITY LEVEL NEEDED//) 
595 CONTINUE 
MM=mm+1 
GO TO 500 
600 CONTINUE 
K=0 












C DETERMINE MINIMUM LEVEL OF ACTIVITY ACCOMPANYING SYMPTOM 
131 
DO 615 K=1.15 
IF4/8(4.K).E0.0.ANU.10(5.K1.EQ.0)G0 TO 615 
IF(I0(4.K).E,i.O.JR.IO(5.K ► .-Q.U)GO TO 607 
IF(18(4.4.1.E0.8.OR.I3(5.0. ► .c4.8)60 TO bOs 
A1=18(4.K ►  
A2=I8(5.K) 
IF(FUNCT(A11.LT.FUNCT(A21)GJ TO 601 
XMINtKO=FUNCT(AZ) 
GO TO 603 
601 XMIN(K)=FUNCT(A1) 
003 CONTINUE 
GO TO 615 
605 IF(L9(4.10.60.0)GO TO o07 
IF(18(4.K).EQ.8)GJ TJ 007 
A3=I8(4,K1 
XMIN(K)=FUNCT(43) 
GO TO 615 







C DETERMINE PATIENT SYMPTOM MATRIX 
C 
C 	DETERMINE IF OYSPNEA IS PRESENT 
IF(I8(1,1).NE.11G0 TO 620 
IF(I8(4.11.EQ.8.OR.I3(5.1).E0.8) GO TO 610 
C EXERTIONAL OYSPNEA IS PRESENT 
x(1)=1.0-KMIN(1) 
GO TO 618 
616 X(21=1.0 
C PAROXYSMAL NOCTURNAL OYSPNEA IS PRESENT 
IF(I6(4,1).E0.0.0R.Id(5.11.EQ.0)G0 TO *20 
xt1i=1.0-xmiN(1) 
618 CONTINUE 
620 IF(I8(1.2).NE.11G0 TO 625 
X(31=812.21 
C COUGH IS PRESENT 
625 IF(I8(1.3).NE.1)G0 TO b30 
IF(IE)(3.3).EQ.1)G0 TO 629 
IF(B(2.2).E0.1.0)GO TO 627 
IF(I8(4.31.0T.5.0R.Id(5.3).GT.5)GO TO 626 
X(4)=.14 
GO TO 630 
626 X(4)=.62 
GO TO 630 
627 IF1118(4,3).GT.5.0R.Id(5,3).Gr.5)G0 TO 628 
X(4)=.7 
GO TO 630 
628 X(4)=.89 
GO TO 632 
629 X(4)=1.0 
C HEMOPTSIS IS PRESENT 
630 IF(I8(1.4).NE.1)G0 TO 635 
C CYANOSIS IS PRESENT 
00 633 I=6.10 
IF(I6(I.4).NE.1.0R.Id(I.4).NE.21G0 TO 631 
X(5)=8(2.4)/2. 
GO TO 633 
631 X(5)=(8(2.41/2.).4-.5 
GO TO 635 
633 CONTINUE 
635 IF(I8(1,5).NE.1) GO TO 640 
X(6)=1.0 
C MALAR FLUSH IS PRESENT 
640 IF(I8(1.6).NE.1)G0 TO 645 
C JAUNDICE IS PRESENT 
X(7)=1.0 
645 IF(I8T1.73.NE.1)G0 TO 651 
X(8) 1.1.0-XMIN(7) 
C WEAKNESS IS PRESENT 
650 IF(I6(1.8).NE.1)GO TO 655 
C FATIGUE IS PRESENT 
Xf91x1.0 -AmIN(4) 
655 IF(I8(1.91.NE.11Go TO bb0 
X(10)=8(2.9) 
C SYNCOPE IS P4r;1NT 
132 
133 
600 	IF(IA(1.10).NE.1)G4 TO bbS 
x(11)=1.0-.XMIN(10) 
665 	IF(I6(1.11).Nt.1)G0 TO 690 
00 685 i=0.10 
IF(16(1.11).E0.10)G0 Ti 000 
IF ( I 8(1 . 1. 1 ). , (1.7.0R.:0(1.11).E0.15)GO TO 670 
IF ( I 0 (I. 11) .EQ.d.OR.16(I.11).EQ.9}GO TO 875 
IF (10 C1 .( 1 ► .E0.13.0R.Id(I.11).E0.14)G0 TO 6d0 
ao TO 685 
C TYPICAL ANGINA IS PRESENT 
666 00 367 J=6.10 
IF(I(i(.1.11).E0.11)GO TO 068 
X(12)=(1.0*XMIN(11))/2. 
GO TO 667 
668 X(12)=(1.0.•XMIN(1I))/2.+.5 
GO TO 685 
667 CONTINUE 
C EPIGASIFIC ANGINAL PAIN IS PRESENT 
670 IF(XMIN(11).LT..1)G0 TO 685 
X(1J) 2 1.0 
GO TO 685 
C PAIN OUE TO ENLARGED LIVER IS PRESENT 
675 X4141 1 1.0 
GO TO 685 
C HEADACHES ARE PRESENT 
680 X(15)=8(2.11) 
685 CONTINUE 
690 IF(I8(1.12).NE.1)G0 TO 700 
DO 694 M=6.10 
IF(IB(M.12).E0.7)G0 TO 698 
694 CONTINUE 
C PERIPHERAL ELENA IS PRESENT 
695 DO 696 MN=6.10 
IF(a(MN.12).NE.4.OR.Id(MN.12).NE.5.0R.Id(MN.12).NE.0)G0 TO 697 
696 CONTINUE 
IF(3(3.12).E0.1.0)G0 TO 693 
X(16)=.24 
GO TO 700 
693 X(16)=.41 
GO TO 700 
697 IF(9(3.12).E0.1.0)G0 TO 699 
X(16)=.79 
GO TO 700 
699 X(16)=1.0 
GO TO 700 
C ASGITES IS PRESENT 
o98 X(17)=1.0 
GO TO 695 
700 CONTINUE 
IF(18(1.13).NE.1)G0 TO 710 
X(18) 1'8(2.13) 
C 	WEIGHT GAIN IS PRESENT 
710 IF(I8(1.14).NE.1)G0 TO 720 
X(19)=1.0 




C THE SIMILARITY BETWEEN THE PATIENTS SYMPTOMS ANO EACH OISEASE SYMPTOMS 
C IS DETERMINED 
DO 850 1=1.15 
00 840 J=1.20 
C 
C 00 NOT CONSIDER SYMPTOMS WHICH HAVE NOT SEEN DESIGNATED AS PRESENT OR 
C ABSENT 
C 
IF(X(JO.E0.8IGNUM)G0 TO 840 
C 
• IF(X(J).GT.XU(I,J)1G0 TO 810 
IF(X(d).LT.XL(i..)))1Sa TO 821 
C 
C THE PATIENT SYMPTOM IS IN THE PROPER SEVERITY INTERVAL FOR OISEASE 
OYSM(I.J)=0.0 
C 
GO TO 830 
C 
C PATIENTS SYMPTOM IS ABOVE LEVELS FOR OISEASE STAGE 
C 
810 OYSM(I,j1=(W(I.j)*(*(J)-xU(I.J)))..Z 
GO TO 830 
C FArILN1j SYAOTOM 13 1L,_OR t.,_VELS FOR oIsL.AsE STAGE 
C 






650 CONTI NUE 
C 
C 
C SUM THE SIMILARITIES BETWEEN PATIENT HISTOKY AND PATIENT SYMPTOMS 
C FOR EACH DISEASE 
C 
J=0 




Y(K11.2)=Dv(J)*XDIS(K4.2 ►  
866 CONTINUE 
C 
DO 735 J=1.20 
IF(X(.11.NE.dIGNUMIGO 70 735 
X(J ► =0.0 
735 CONTINUE 
WRITE(6,740) 
740 FoRMAT(///14HHISTORY NUM0Ek.10x.19HPRESENCE OF HISTORY ►  





750 FOKMAT(///14H5YMTPOM NUMBEK.10X,I7HLEVEL OF SEVERITY) 
DO 760 11.1.20 
WRITE(6.755 ► II.x(II) 
755 FORMAT(5X,12.70X.Fo.3) 
760 CONTINUE 
C ORDER THE SIMILARITIES BETWEEN THE PATIENTS SICKNESS ANO DISEASES 
C 




870 DO 880 K=2.15 





C FIND THE MOST SIMILAR OISEASE ANO ORDER THE OISEASES WITH RESPECT 
C TO SIMILARITY WITH THE PATIENTS SICKNESS 
C 
00 900 J=1.15 
L(J)=KMAx 
YMIN(J)=YMAX 
DO 895 I=1.15 
C 
C ELIMINATE DISEASES ALREADY ORDERED 
C 
IF(J.EQ.1)G0 TO 891 
NN=J-1 
00 890 M=1.NN 
IFYL(M).EQ.I/G0 TO 895 
890 CONTINUE 
891 CONTINUE 







C PRINT A TABLE OF THE JRDEREO SIMILARITIES 
C 
WRITE(6,910) 
910 FORMAt(//,52MTME SIMILARITY MEASURES BETWEEN tHE PATIENTS DISEASE/ 
145HANO OISEASE I ARE GIVEN IN THE FOLLOWING TABLE///20X.ZIHTABLE 0 
2F SIMILARITIES//1 
WRITE(6.920, 
920 FORMAT(10X•8140kUER OF.L0X,7MDI:aEASE,I0X,IAMSIMILARITY/10V,I8NSIMIL. 
IARITY. 8V•ENNUMBE.31X.7MMEAIURE/1 
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